Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

März Winfried |

Presentations at scientific and public conferences

Herrmann, M; Keppel, M; Zelzer, S; Pilz, S; Scharnagl, H; Kleber, M; März, W The role of functional vitamin D deficiency and low vitamin D reservoirs in relation to cardiovascular health and mortality
CLIN CHIM ACTA. Abstracts. 2024; 558: 118230--26th International Federation of Clinical Chemistry and Laboratory Medicine (IFCC); MAY 26-30, 2024; Dubai, UAE. Doi: 10.1016/j.cca.2024.118230 [Poster]
Web of Science FullText FullText_MUG

 

Herrmann, M; Zelzer, S; Cavalier, E; Kleber, M; Drexler-Helmberg, C; Schlenke, P; Curcic, P; Keppel, M; Enko, D; Scharnagl, H; Pilz, S; März, W Personalized assessment of vitamin D status by a novel metabolic approach.
CLIN CHIM ACTA. 2024; 558: 118232--26th International Congress of Clinical Chemistry and Laboratory Medicine; MAY 26-30, 2024; Dubai, UNITED ARAB EMIRATES. Doi: 10.1016/j.cca.2024.118232 [Poster]
Web of Science FullText FullText_MUG

 

März, W; Herrmann, M; Zelzer, S; Delgado, G; Kleber, M; Pilz, S VITAMIN D AND CARDIO-VASCULAR HEALTH
ANTICANCER RES. 2024; 44(5): [Oral Communication]
Web of Science FullText

 

Zelzer, S; Herrmann, M; Cavalier, E; Kleber, M; Keppel, MH; Enko, D;Scharnagl, H; Pilz, S; MärzW Personalized assessment of vitamin D status by a novel metabolic approach.
Anticancer Research; International Journal of Cancer Research and Treatment. 2024; 44: 2249-2270.-Joint International Symposium - Vitamin D in prevention and therapy & biologic effects of light; MAY 8-10, 2024; Homburg, GERMANY. (ISBN: 0250-7005 ) [Oral Communication]
FullText

 

Blanke, P; Moissl, A; Ivandic, M; Ivandic, M; März, W; Lorkowski, S PREVALENCE OF DYSLIPIDAEMIA IN GERMANY
ATHEROSCLEROSIS. 2023; 379: S97-S97. [Poster]
Web of Science

 

Fath, F; März, W; Schmidt, N; Haak, IA; Dressel, A; Grammer, T; Kleber, M; Bässler, A; Beil, FU; Gouni-Berthold, I; Julius, U; Kassner, U; Katzmann, JL; Klose, G; König, C; Koenig, W; Koschker, AC; Laufs, U; Merkel, M; Otte, B; Parhofer, K; Hengstenberg, W; Schunkert, H; Stach-Jablonski, K; Steinhagen-Thiessen, E; Olivier, C; Hahmann, H; Krzossok, S; Vogt, A; Müller-Wieland, D; Schatz, U THE GERMAN CARE HIGH REGISTRY FOR FAMILIAL HYPERCHOLESTEROLEMIA -SEX DIFFERENCES, TREATMENT STRATEGIES, AND TARGET VALUE ATTAINMENT
ATHEROSCLEROSIS. 2023; 379: S124-S124. [Poster]
Web of Science

 

Herrmann, M; Zelzer, S; Kleber, M; Drexler-Helmberg, C; Schlenke, P; Curcic, P; Enko, D; Scharnagl, H; Pilz, S; März, W Increased all-cause mortality in individuals with functional vitamin D deficiency
Heft der Zeitschrift Clinical Chemistry and Laboratory Medicine (CCLM). 2023; 61(S1):-XXV IFCC-EFLM EuroMedLab-WorldLab Congress 2023; May 21-25, 2023; Rom, ITALIEN;. [Keynote lecture]
FullText

 

Horstmann, H; Anto-Michel, N; Kueckelhaus, J; Hansen, S; Marchini, T; Olawale, T; Gissler, C; Heiland, H; Maerz, W; Westermann, D; Zirlik, A; Wolf, D Single-cell RNA-sequencing to interrogate TCR-Repertoire and antigen-specificity in human atherosclerosis
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Leiherer, A; Muendlein, A; Brandtner, EM; Saely, C; Vonbank, A; Mader, A; Sprenger, L; Maechler, M; Larcher, B; Plattner, T; Jylha, A; Laaperi, M; Laaksonen, R; Marz, W; Fraunberger, P; Kleber, M; Drexel, H CERAMIDE-BASED LIPID PROFILES AND THE PREVALENCE OF TYPE 2 DIABETES DIFFER BETWEEN PATIENTS WITH CORONARY ARTERY DISEASE AND THOSE WITH PERIPHERAL ARTERY DISEASE
ATHEROSCLEROSIS. 2023; 379: [Poster]
Web of Science

 

Moissl, A; Delgado, G; Kleber, M; Krämer, B; März, W; Lorkowski, S DEFICIENCY OF MICRONUTRIENTS AND KIDNEY FUNCTION: THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH (LURIC) STUDY
ATHEROSCLEROSIS. 2023; 379: S165-S165. [Poster]
Web of Science

 

Moissl, A; Delgado, G; Kleber, M; März, W; Krämer, B; Pilz, S; Scharnagl, H; Siekmeier, R; Silbernagel, G; Tomaschitz, A; Winklhofer-Roob, B; Lorkowski, S ASSOCIATIONS OF CAROTENOIDS, VITAMIN A AND MORTALITY: THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH (LURIC) STUDY
ATHEROSCLEROSIS. 2023; 379: S164-S165.-91st Annual Meeting of the European-Atherosclerosis-Society (EAS); MAY 21-24, 2023; Mannheim, GERMANY. [Poster]
Web of Science

 

Moissl, A; Lorkowski, S; Meinitzer, A; Pilz, S; Scharnagl, H; Delgado, G; Kleber, M; Krämer, B; Pieske, B; Grübler, M; Brussee, H; Von Lewinski, D; Toplak, H; Fahrleitner-Pammer, A; März, W; Tomaschitz, A HEAT FAILURE WITH PRESERVED EJECTION FRACTION. ASSOCIATION OF BRANCHED-CHAIN AMINO ACIDS WITH MORTALITY RISK IN THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH (LURIC) STUDY
ATHEROSCLEROSIS. 2023; 379: S140-S140.-91st Annual Meeting of the European-Atherosclerosis-Society (EAS); MAY 21-24, 2023; Mannheim, GERMANY. [Poster]
Web of Science

 

Molnar, S; Scharnagl, H; Laufs, U; März, W; Kleber, M; Katzmann, JL DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA WITH CLINICAL CRITERIA AND GENETIC TESTING IN PATIENTS SCHEDULED FOR CORONARY ANGIOGRAPHY
ATHEROSCLEROSIS. 2023; 379: -91st Annual Meeting of the European-Atherosclerosis-Society (EAS); MAY 21-24, 2023; Mannheim, GERMANY. [Poster]
Web of Science

 

Scharnagl, H; Kannenkeril, D; Stojakovic, T; Silbernagel, G; Bosch, A; März, W; Schmieder, R EFFECT OF PCSK9 INHIBITION WITH EVOLOCUMAB ON THE CONCENTRATION AND COMPOSITION OF LDL SUBFRACTIONS IN HIGH-RISK PATIENTS WITH CARDIOVASCULAR DISEASE
ATHEROSCLEROSIS. 2023; 379: S71-S71. [Poster]
Web of Science FullText

 

Silbernagel, G; Scharnagl, H; Rief, M; Walzer, J; Kleber, M; März, W THE PREDICTIVE VALUE OF THE SMART RISK SCORE IN PATIENTS REFERRED FOR CORONARY ANGIOGRAPHY
ATHEROSCLEROSIS. 2023; 379: S194-S194. [Poster]
Web of Science FullText

 

Yazdani, B; Delgado, G; Kleber, M; Yücel, G; Husain-Syed, F; Kraemer, T; Jochims, J; Leipe, J; März, W; Krämer, B THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, NEUROHUMORAL AXIS AND CARDIOVASCULARMORTALITY IN LURIC
ATHEROSCLEROSIS. 2023; 379: S205-S205. [Poster]
Web of Science

 

Zelzer, S; Kleber, M; Drexler-Helmberg, C; Schlenke, P; Curcic, P; Enko, D; Scharnagl, H; Pilz, S; März, W; Herrmann, M Accelerated bone metabolism in individuals with functional vitamin D deficiency
Heft der Zeitschrift Clinical Chemistry and Laboratory Medicine (CCLM). 2023; 61(S1):-XXV IFCC-EFLM EuroMedLab-WorldLab Congress 2023; May 21-25, 2023; Rom, ITALIEN;. [Poster]
FullText

 

Zheng, J; Smith, GD; Kavousi, M; Brumpton, B; Langenberg, C; Andlauer, T; Maerz, W; Ohlsson, C; Holmes, M; Tobias, J Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: evidence from a genome-wide association meta-analysis followed by Mendelian randomization
J BONE MINER RES. 2023; 38: 8-8. [Poster]
Web of Science

 

Frysz, M; Gergei, I; Scharnag, H; Smith, GD; Zheng, J; Lawlor, D; Herrmann, M; Maerz, W; Tobias, J Circulating sclerostin levels are positively related to coronary artery disease severity and related risk factors
J BONE MINER RES. 2022; 37: 64-64.-Annual Meeting of the American-Society-for-Bone-and-Mineral-Research (ASBMR); OCT 01-04, 2021; San Diego, CA. [Poster]
Web of Science

 

Grubler, M; Fielder, L; Tscharre, M; Haiden, A; Pfeffer, M; Hartmann, A; Thianich, F; Roithinger, FX; Verheyen, N; Trummer, C; Theiler-Schwetz, V; Pilz, S; Maerz, W Markers of bone metabolism are associated in all-cause mortality in heart failure with reduced ejection fraction
EUR HEART J. 2022; 43: 844-844.
Web of Science

 

Leiherer, A; Muendlein, A; Brandtner, E; Saely, CH; Vonbank, A; Mader, A; Sprenger, L; Maechler, M; Jylha, A; Laaperi, M; Laaksonen, R; Maerz, W; Fraunberger, P; Kleber, M; Drexel, H Ceramide-based lipid profiles and the prevalence of type 2 diabetes differ between patients with coronary artery disease and those with peripheral artery disease
EUR HEART J. 2022; 43: 3073-3073.
Web of Science

 

Leiherer, A; Muendlein, A; Brandtner, EM; Saely, CH; Vonbank, A; Mader, A; Sprenger, L; Maechler, M; Larcher, B; Jylha, A; Laaperi, M; Laaksonen, R; Maerz, W; Fraunberger, P; Kleber, M; Drexel, H Ceramide-based lipid profiles and the prevalence of type 2 diabetes differ between patients with coronary artery disease and those with peripheral artery disease
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):247-248. [Poster]
Web of Science

 

Rief, M; Raggam, R; Rief, P; Metnitz, P; Stojakovic, T; Reinthaler, M; Brodmann, M; März, W; Scharnagl, H; Silbernagel, G; Comparison of two Nuclear Magnetic Resonance Spectroscopy Methods for the Measurement of Lipoprotein Particle Concentrations
-. 2022; -Docday2022; FEB 10, 2022; Graz, AUSTRIA. [Onlinepräsentation]

 

Rief, Martin; Raggam, Reinhard; Rief, Peter; Metnitz, Philipp; Stojakovic, Tatjana; Reinthaler, Markus; Brodmann, Marianne; März, Winfried; Scharnagl, Hubert; Silbernagel, G; Comparison of two Nuclear Magnetic Resonance Spectroscopy Methods for the Measurement of Lipoprotein Particle Concentrations
VMAC 2022; MAR 17-19, 2022; Augsburg, GERMANY. 2022. [Onlinepräsentation]

 

Schmitz, B; Gatsios, D; Pena-Gil, C; Juanatey, JRG; Prieto, DC; Tsakanikas, V; Scharnagl, H; Habibovic, M; Schmidt, M; Kleber, ME; De Bruijn, GJ; Malberg, H; Mooren, F; Widdershoven, J; Maerz, W; Fotiadis, D; Kop, WJ; Bosch, J PATIENT-CENTERED CARDIAC REHABILITATION BY AI-POWERED LIFESTYLE INTERVENTION - THE TIMELY APPROACH
ATHEROSCLEROSIS. 2022; 355: E333-E333. [Poster]
Web of Science

 

Silbernagel, G; Duarte, K; Sadiku, S; Fauler, G; Maerz, W; Schmieder, RE; Jardine, AG; Massy, ZA; Girerd, N; Fellstrom, B; Scharnagl, H; Zannad, F HIGH CHOLESTEROL ABSORPTION IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK IN HEMODIALYSIS PATIENTS: INSIGHTS FROM THE AURORA STUDY
ATHEROSCLEROSIS. 2022; 355: E14-E14. [Poster]
Web of Science

 

Silbernagel, G; Duarte, K; Sadiku, S; Fauler, G; März, W; Schmieder, RE; Jardine, AG; Massy, ZA; Girerd, N; Fellström, B; Rossignol, P; Scharnagl, H; Zannad F High cholesterol absorption is associated with increased cardiovascular risk in haemodialysis patients: insights from the AURORA study.
https://cslide.ctimeetingtech.com/eas22/attendee/confcal/session/calendar/2022-05-23. 2022; -90th European Atherosclerosis Society Congress; May 22-25; Milan, Italy. [Keynote lecture]

 

Silbernagel, G; Scharnagl, H; Kleber, ME; März, W Association between circulating apoc-II and cardiovascular mortality
JACC March 8, 2022; suppl. A. 2022; 79(9):-ACC.22: ACC’s 71st Annual Scientific Session & Expo; April 2 – 4, 2022; Washington, US. [Keynote lecture]
FullText

 

Silbernagel, G; Scharnagl, H; Reinthaler, M; Rief, M; Kleber, M; Chapman, JM; Schaefer, JR; Maerz, W; The LDL-ApoB to LDL- Cholesterol Ratio Reflects the Amount of Small Dense LDL Particles and is Associated with Cardiovascular Mortality
VMAC 2022; MAR 17-19, 2022; Augsburg, GERMANY. 2022. [Keynote lecture]

 

Vosko, I; Gollmer, J; Hilvo, M; Jylha, A; Laaksonen, R; Marz, W; Zirlik, A; Bugger, H Unsaturated ceramides as independent predictor for cardiovascular mortality in diabetic and non-diabetic subjects with coronary artery disease
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 2):173-173. [Poster]
Web of Science

 

Grubler, M; Verheyen, ND; Meinitzer, A; Tascharre, M; Fiedler, L; Roithinger, FX; Maerz, W; Tomaschitz, A; Pilz, S Association of female sexual hormones with QTc time in hypertensive subjects
EUR HEART J. 2021; 42: 639-639. [Poster]
Web of Science

 

Grubler, MR; Verheyen, ND; Meinitzer, A; Fiedler, L; Tscharre, M; Roithinger, FX; Tomaschitz, A; Pilz, S; Maerz, W Digoxin treatment and long-term mortality depending on left ventricular ejection fraction and atrial fibrillation: a propensity score matched analysis
EUR HEART J. 2021; 42: 502-502. [Poster]
Web of Science

 

Moissl, AP; Dawczynski, C; Delgado, GE; Kleber, ME; Marz, W; Kramer, BK; Pilz, S; Scharnagl, H; Siekmeier, R; Silbernagel, G; Tomaschitz, A; Winkelhofer-Roob, B; Lorkowski, S Carotenoids, Vitamin A and mortality: The Ludwigshafen Risk and Cardiovascular Health (-LURIC) study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 5):188-189. [Poster]
Web of Science

 

Moissl, AP; Delgado, GE; Kramer, BK; Dawczynski, C; Stojakovic, T; Marz, W; Kleber, ME; Lorkowski, S Alcohol consumption in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 5):188-188. [Poster]
Web of Science

 

Drechsler, C; Menitzer, A; Maerz, W; Gutjahr-Lengsfeld, L; Oder, D; Uceyler, N; Sommer, C; Nordbeck, P; Wanner, C HOMOARGININE ASSOCIATES WITH RENAL AND CARDIAC FUNCTION IN FABRY DISEASE.
NEPHROL DIAL TRANSPL. 2020; 35: 372-372.-57th ERA-EDTA Congress; JUN 06-09, 2020; ELECTR NETWORK. [Poster]
Web of Science

 

Siekmeier, R; Grammer, T; Marz, W Tests for diagnostics of COVID-19-principles and approvals of commercially available tests.
WIEN KLIN WOCHENSCHR. 2020; 132(19-20):616-617. [Poster]
Web of Science

 

Herrmann, M; Pusceddu, I; Kleber, ME; Scharnagl, H; Marz, W; Herrmann, W SHORT TELOMERES, A COMMON RISK FACTOR OF ALL CAUSE AND CARDIOVASCULAR MORTALITY IN VITAMIN B- AND D-DEFICIENT SUBJECTS
ANTICANCER RES. 2019; 39(6):3279-3279. [Poster]
Web of Science

 

Kalsch, AI; Kleber, M; Sattler, W; Kramer, BK; Marz, W; Malle, E; Leipe, J; Scharnagl, H LONG- AND SHORT-TERM ASSOCIATION OF LOW-GRADE SYSTEMIC INFLAMMATION WITH CARDIOVASCULAR MORTALITY
J HYPERTENS. 2019; 37: E295-E295.-29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH); JUN 21-24, 2019; Milan, ITALY. Doi: 10.1097/01.hjh.0000573732.10100.c2 [Oral Communication]
Web of Science FullText FullText_MUG

 

Kassner, U; Hollstein, T; Schumann, F; Grenkowitz, T; Scharnagl, H; Marz, W; Steinhagen-Thiessen, E PROPROTEIN CONVERTASE SUBTILISIN/ KEXIN TYPE 9 ANTIBODIES (PCSK9-I) TREATMENT OF CARDIOVASCULAR HIGH RISK PATIENTS IN CLINICAL PRACTICE
ATHEROSCLEROSIS. 2019; 287: E212-E212.-87th Congress of the European-Atherosclerosis-Society (EAS); MAY 26-29, 2019; Maastricht, NETHERLANDS. Doi: 10.1016/j.atherosclerosis.2019.06.645 [Poster]
Web of Science FullText FullText_MUG

 

Leipe, J; Kaelsch, AI; Kleber, M; Scharnagl, H; Sattler, W; Marz, W; Malle, E; Kraemer, B LONG- AND SHORT-TERM ASSOCIATION OF LOW-GRADE SYSTEMIC INFLAMMATION WITH CARDIOVASCULAR MORTALITY
ANN RHEUM DIS. 2019; 78: 1028-1028.-Annual European Congress of Rheumatology (EULAR); JUN 12-15, 2019; Madrid, SPAIN. Doi: 10.1136/annrheumdis-2019-eular.7919 [Oral Communication] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Mader, A; Muendlein, A; Leiherer, A; Saely, C; Geiger, K; Brandtner, EM; Larcher, B; Fraunberger, P; Kleber, M; Dressel, A; Maerz, W; Drexel, H Elevated parathyroid hormone is associated with an increased mortality risk in type 2 diabetes
EUR J CLIN INVEST. 2019; 49: 148-148. [Poster]
Web of Science

 

Meinitzer, A; Enko, D; Zelzer, S; Reibnegger, G; Herrmann, M; Rosenkranz, A; März, W; Zitta, S Estimation of the glomerular filtration rate using SDMA as an index of kidney function
Symposium: The cardiorenal axis. From risk stratification to personalized treatment.; JAN 16-19, 2019; Mannheim, GERMANY. 2019. [Poster]

 

Renner, W; Winklhofer-Roob, B; Kleber, M;, März, W The haptoglobin genotype modifies the relationship between vitamin E and mortality
The Cardiorenal Axis - From risk stratification to personalized treatment; JAN 17-18, 2019; Mannheim, GERMANY. 2019. [Poster]

 

Saternus, R; Pilz, S; Graber, S; Kleber, M; Marz, W; Vogt, T; Reichrath, J VITAMIN D ENDOCRINE SYSTEM, SKIN PIGMENTATION AND EVOLUTION: ASSOCIATION OF VITAMIN D STATUS WITH SINGLE NUCLEOTIDE POLYMORPHISMS OF GENES INVOLVED IN SKIN PIGMENTATION
ANTICANCER RES. 2019; 39(6):3292-3292. [Oral Communication]
Web of Science

 

Siekmeier, R; Hannig, J; Grammer, T; Marz, W Incorrect laboratory results due to Fulvestrant Intake - Analysis of Customer Information on In-vitro Diagnostics (IVD) published by BfArM 2015-2019
WIEN KLIN WOCHENSCHR. 2019; 131: S441-S441. [Poster]
Web of Science

 

Siekmeier, R; Hannig, J; Grammer, T; Marz, W Incorrect Laboratory Results due to Biotin Intake - Analysis of Customer Information on In-vitro Diagnostics (IVD) published by BfArM 2015-2019
WIEN KLIN WOCHENSCHR. 2019; 131: S440-S440. [Poster]
Web of Science

 

Silbernagel, G; Scharnagl, H; Kleber, ME; Hoffmann, MM; Delgado, G; Stojakovic, T; Gary, T; Zeng, L; Ritsch, A; Zewinger, S; Speer, T; Schunkert, H; Landmesser, U; Marz, W; Grammer, T COMMON APOC3 VARIANTS AND CORONARY ARTERY DISEASE
ATHEROSCLEROSIS. 2019; 287: E61-E62.-87th Congress of the European-Atherosclerosis-Society (EAS); MAY 26-29, 2019; Maastricht, NETHERLANDS. Doi: 10.1016/j.atherosclerosis.2019.06.175 [Poster]
Web of Science FullText FullText_MUG

 

Stöhr, R; Scharnagl, H; Enko, D; März, W; Marx, N; Brandenburg, V FGF-23 and iron metabolism
Symposium: The cardiorenal axis. From risk stratification to personalized treatment.; JAN 16-19, 2019; Mannheim, GERMANY. 2019. [Poster]

 

Yazdani, B; Kleber, M; Yucel, G; Benck, U; Marz, W; Kramer, B ASSOCIATION OF PULSE PRESSURE AND DOUBLE PRODUCT WITH CARDIOVASCULAR AND OVERALL MORTALITY IN LURIC
J HYPERTENS. 2019; 37: E227-E227.-29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH); JUN 21-24, 2019; Milan, ITALY. Doi: 10.1097/01.hjh.0000572908.93676.78 [Poster]
Web of Science FullText FullText_MUG

 

Enko, D; Meinitzer, A; Scharnagl, H; Stojakovic, T; Kleber, ME; Delgado, GE; Zelzer, S; Drechsler, C; Krämer, BK; Wanner, C; März, W; Woitas, RP Beta trace protein and mortality.
Symposium: Biomarker of the cardiorenal axis; JAN 17-19, 2018; Würzburg, GERMANY. 2018. [Poster]

 

Enko, D; Meinitzer, A; Scharnagl, H; Stojakovic, T; Kleber, ME; Delgado, GE; Zelzer, S; Drechsler, C; Krämer BK; Wanner, C; März, W; Woitas RP Beta-trace protein and mortality in hemodialysis patients - beyond kidney function.
34th World Congress of Internal Medicine; OKT 18-21, 2018; Cape Town, SOUTH AFRICA. 2018. [Poster]

 

Enko, D; Meinitzer, A; Schnedl WJ; Halwachs-Baumann G; Kriegshäuser G Assessment of serum lipid levels in patients with depressive disorder and healthy controls.
34th World Congress of Internal Medicine; OKT 18-21, 2018; Cape Town, SOUTH AFRICA. 2018. [Poster]

 

Francic V, Gaksch M, Schwetz V, Trummer C, Pandis M, Aberer F, Grübler M, Verheyen N, März W, Tomaschitz A, Pilz S, Obermayer-Pietsch B Vitamin D and sST2 in a randomized controlled trial with vitamin D supplemented hypertensive patients
Osteologie 2018; 27(01): A1-A53 DOI: 10.1055/s-0038-1636979. 2018; -OSTEOLOGIE 2018 Dresden; MAR 8-10, 2018; Dresden. [Poster]
FullText

 

Francic V, Gaksch M, Schwetz V, Trummer C, Pandis M, Aberer F, Grübler M, Verheyen ND, März W, Pieber TR, Tomaschitz A, Pilz S, Obermayer-Pietsch B Levels of soluble ST2 are unaffected by vitamin D supplementation
Abstracts of the ECTS Congress 2018 Calcif Tissue Int (2018) 102(Suppl 1): 1. https://doi.org/10.1007/s00223-018-0418-0. 2018; -ECTS Congress 2018; MAY 26-29; Valencia. [Poster]
FullText

 

Francic V, Gaksch M, Schwetz V, Trummer C, Pandis M, Aberer F, Grübler M, Verheyen ND, März W, Pieber TR, Tomaschitz A, Pilz S, Obermayer-Pietsch B Soluble ST2, a promising cardiovascular biomarker, is associated with parameters of glucose and bone metabolism in subjects at cardiovascular risk
Endocrine Abstracts published by bioscientifica May 2018. 2018; 56: -ECE 2018, 20th European Congress of Endocrinology; MAY 19-22, 2018; Barcelona. [Poster]
FullText

 

Francic V, Ursem S, Gaksch M, Schwetz V, Trummer C, Pandis M, Aberer F, Grübler M, Verheyen N, März W, Tomaschitz A, Pilz S, Heijboer A, Obermayer-Pietsch B Effects of vitamin D supplementation on its metabolism in vitamin D insufficient adults
Osteologie 2018; 27(01): A1-A53 DOI: 10.1055/s-0038-1636979. 2018; -OSTEOLOGIE 2018 Dresden; MAR 8-10, 2018; Dresden. [Oral Communication]
FullText

 

Gergei, I; Pfau, T; Kramer, BK; Schneider, J; Marz, W; Sauter, T CARDIOVASCULAR RISK PREDICTION - A SYSTEMS MEDICINE APPROACH
J HYPERTENS. 2018; 36: E32-E32.-28th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH); JUN 08-11, 2018; Barcelona, SPAIN. Doi: 10.1097/01.hjh.0000539796.94847.e3 [Poster]
Web of Science FullText FullText_MUG

 

Hollstein, T; Grenkowitz, T; Scharnagl, H; Marz, W; Steinhagen-Thiessen, E; Kassner, U PCSK9-INHIBITOR TREATMENT OF CARDIOVASCULAR HIGH RISK PATIENTS IN CLINICAL PRACTICE - NEW DATA REGARDING SAFETY AND EFFECTIVITY
ATHEROSCLEROSIS. 2018; 275: E31-E31.-86th Congress of the European-Atherosclerosis-Society (EAS); MAY 05-08, 2018; Lisbon, PORTUGAL. Doi: 10.1016/j.atherosclerosis.2018.06.077 [Poster]
Web of Science FullText FullText_MUG

 

Hollstein, T; Grenkowitz, T; Scharnagl, H; Marz, W; Steinhagen-Thiessen, E; Kassner, U PCSK9-inhibitor treatment of cardiovascular high risk patients in clinical practice - new data regarding safety and effectivity
INTERNIST. 2018; 59: S11-S12. [Poster]
Web of Science

 

Kleber, M; Lyytikainen, LP; Delgado, GE; Drechsler, C; Wanner, C; Meinitzer, A; Lehtimaki, T; Kramer, BK; Marz, W GENOME WIDE ASSOCIATION STUDY META-ANALYSIS OF HOMOARGININE USING THE HRC REFERENCE PANEL
J HYPERTENS. 2018; 36: E94-E94.-28th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH); JUN 08-11, 2018; Barcelona, SPAIN. Doi: 10.1097/01.hjh.0000539237.28179.dd [Oral Communication]
Web of Science FullText FullText_MUG

 

Muendlein, A; Leiherer, A; Saely, CH; Geiger, K; Brandtner, EM; Larcher, B; Mader, A; Fraunberger, P; Kleber, M; Dressel, A; Maerz, W; Drexel, H Elevated parathyroid hormone is associated with an increased mortality risk in type 2 diabetes
EUR HEART J. 2018; 39: 999-999.
Web of Science

 

Muendlein, A; Leiherer, A; Saely, CH; Geiger, K; Brantner, EM; Larcher, B; Mader, A; Ebner, KM; Fraunberger, P; Kleber, M; Dressel, A; Maerz, W; Drexel, H Elevated parathyroid hormone is associated with an increased mortality risk in type 2 diabetes
WIEN KLIN WOCHENSCHR. 2018; 130: 355-355. [Poster]
Web of Science

 

Ritsch, A; Duerr, A; Kahler, P; Hunjadi, M; Stojakovic, T; Zewinger, S; Speer, T; Silbernagl, G; Scharnagl, H; Kleber, M; Marz, W INDEPENDENT EFFECTS OF KIDNEY FUNCTION AND CHOLERSTEROL EFFLUX ON CARDIOVASCULAR MORTALITY
ATHEROSCLEROSIS. 2018; 275: E28-E28.-86th Congress of the European-Atherosclerosis-Society (EAS); MAY 05-08, 2018; Lisbon, PORTUGAL. Doi: 10.1016/j.atherosclerosis.2018.06.072 [Poster]
Web of Science FullText FullText_MUG

 

Ursem S, Francic V, Gaksch M, Schwetz V, Trummer C, Pandis M, Aberer F, Grübler M, Verheyen N, März W, Tomaschitz A, Pilz S, Heijboer A, Obermayer-Pietsch B The effect of vitamin D supplementation on plasma non-oxidized PTH concentration
Osteologie 2018; 27(01): A1-A53 DOI: 10.1055/s-0038-1636979. 2018; -OSTEOLOGIE 2018 Dresden ; MAR 8-10, 2018; Dresden. [Oral Communication]
FullText

 

Werner, C; Stojakovic, T; Speer, T; Zewinger, S; Maerz, W; Scharnagl, H; Laufs, U Apolipoprotein C-III concentrations in chylomicron-free serum predict cardiovascular outcomes in patients with coronary artery disease
EUR HEART J. 2018; 39: 753-753.-European-Society-of-Cardiology Congress; AUG 25-29, 2018; Munich, GERMANY. [Poster]
Web of Science

 

Zelzer, S; Enko, D; Pilz, S; Tomaschitz, A; März, W; Meinitzer, A Link between myeloperoxidase, asymmetric dimethylarginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients: Cross-sectional findings from the Ludwigshafen Risk and Cardiovascular health (LURIC) study.
Symposium: Biomarker of the cardiorenal axis; JAN 17-19, 2018; Würzburg, GERMANY. 2018. [Poster]

 

Baumstark, D; Neumann, S; Eiglsperger, J; Norkauer, S; Wieczorek, J; Fuhrmann, M; Mundner, M; Wack, J; Scharnagl, H; Stojakovic, T; Marz, W; Pagel, P LIPOPROTEIN PROFILING WITH THE AXINON (R) SYSTEM
ATHEROSCLEROSIS. 2017; 263: E201-E201.-85th Congress of the European-Atherosclerosis-Society (EAS); APR 23-26, 2017; Prague, CZECH REPUBLIC. Doi: 10.1016/j.atherosclerosis.2017.06.648 [Poster]
Web of Science FullText FullText_MUG

 

Burgard, B; Schope, J; Holzschuh, I; Schiekofer, C; Reichrath, S; Marz, W; Ordonez-Mena, J; Pilz, S; Vogt, T; Wagenpfeil, S; Reichrath, J AN UPDATE ON SOLARIUM USE AND RISK FOR MALIGNANT MELANOMA: A CRITICAL SYSTEMATIC REVIEW AND META-ANALYSIS
ANTICANCER RES. 2017; 37(6):3344-3344. [Poster]
Web of Science

 

Dressel, A; Marz, W; Schmidt, B; Laufs, U; Schmidt, N COST-EFFECTIVENESS OF PCSK9 INHIBITOR THERAPY FOR PATIENTS WITH STABLE CAD IN GERMANY
ATHEROSCLEROSIS. 2017; 263: E160-E161.-85th Congress of the European-Atherosclerosis-Society (EAS); APR 23-26, 2017; Prague, CZECH REPUBLIC. Doi: 10.1016/j.atherosclerosis.2017.06.510 [Poster]
Web of Science FullText FullText_MUG

 

Enko, D; Meinitzer, A; Scharnagl, H; Stojakovic T; Kleber, ME; Delgado, GE; Zelzer, S; Drechsler, C; Krämer, BK; Wanner, C; März, W; Woitas, RP Beta-trace protein, renal function, and clinical outcomes: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) and 4D Studies.
Symposium: Biomarkers of the cardiorenal axis; JAN 19-20; 2017; Mannheim, GERMANY. 2017. [Poster]
FullText

 

Marz, W; Pilz, S CHALLENGE AND PROMISE: THE RELEVANCE OF VITAMIN D FOR PREVENTIVE MEDICINE
ANTICANCER RES. 2017; 37(6):3339-3339. [Poster]
Web of Science

 

Saternus, R; Rossberg, W; Pilz, S; Graber, S; Wagenpfeil, S; Kleber, M; Marz, W; Reichrath, S; Vogt, T; Reichrath, J HUMAN PIGMENTATION, CUTANEOUS VITAMIN D SYNTHESIS AND EVOLUTION: VARIANTS OF GENES (SNPS) INVOLVED IN SKIN PIGMENTATION ARE ASSOCIATED WITH 25(OH)D SERUM CONCENTRATION
ANTICANCER RES. 2017; 37(6):3353-3353. [Poster]
Web of Science

 

Schmid, J; Stojakovic, T; Scharnagl, H; Maderthaner, RD; Zweiker, D; Scherr, D; Schmidt, A; März, W; Binder, JS; Rainer, PP ST2 Predicts Survival in Patients Undergoing Transcatheter Aortic Valve Implantation
Annual meeting of the Working Groups on Myocardial Function and the Working Group on Cellular Biology of the Heart: The multicellularity of the heart: genetic innovations driving cardiovascular science; May 25-28, 2017; Varenna, Italy. 2017. [Poster]

 

Schmid, J; Stojakovic, T; Zweiker, D; Scharnagl, H; Maderthaner, RD; Scherr, D; Maier, R; Schmidt, A; März, W; Binder, JS; Rainer, PP Comparison of Novel Biomarkers ST2, Galectin 3 and FGF23 for Prediction of Survival in Patients Undergoing Transcatheter Aortic Valve Implantation
CardioFlame Symposium; NOV 23-24, 2017; Graz, AUSTRIA. 2017. [Poster]

 

Schmid, J; Stojakovic, T; Zweiker, D; Scharnagl, H; Maderthaner, RD; Scherr, D; Maier, R; Schmidt, A; März, W; Binder, JS; Rainer, PP ST2 predicts survival in patients undergoing transcatheter aortic valve implantation
CardioFlame 2017; Nov 20, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

 

Schmid, J; Zweiker, D; Stojakovic, T; Scharnagl, H; Maderthaner, R; Scherr, D; Maier, R; Schmidt, A; März, W; Binder, J; Rainer, P ST2 predicts survival in patients undergoing transcatheter aortic valve implantation
WIEN KLIN WOCHENSCHR. 2017; 129 (Suppl 1): S102. 2017; -ÖKG Jahrestagung; JUN 7-10, 2017; Salzburg, AUSTRIA. [Poster]

 

Schmidt, N; Dressel, A; Marz, W FIRST DATA FROM THE GERMAN CASCADE SCREENING PROGRAM FOR FAMILIAL HYPERCHOLESTEROLEMIA - CARE HIGH
ATHEROSCLEROSIS. 2017; 263: E233-E234.-85th Congress of the European-Atherosclerosis-Society (EAS); APR 23-26, 2017; Prague, CZECH REPUBLIC. Doi: 10.1016/j.atherosclerosis.2017.06.761 [Poster]
Web of Science FullText FullText_MUG

 

Schweighofer, N; Genser, B; Maerz, W; Kleber, ME; Pieber, TR; Obermayer-Pietsch, B Metformin users with specific Oct1 gene variants have a higher risk of cardiovascular death.
Endocrine Abstracts. 2017; -ECE; MAY 20-23, 2017; Lisbon, PORTUGAL. [Poster]

 

Siekmeier, R; Delgado, G; Titze, L; Grammer, T; Pilz, S; Kleber, M; Marz, W Role of vitamin D deficiency in chronic obstructive pulmonary disease - an overview
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):759-759. [Poster]
Web of Science

 

Silbernagel, G; Scharnagl, H; Kleber, M; Stojakovic, T; März W CIRCULATING PCSK9 IS NOT ASSOCIATED WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITY
Journal of the American College of Cardiology WOS:000397342302384 . 2017; 69(9):1662-1662.-ACC.17: 66th Annual Scientific Session & Expo; Mar 17-19, 2017; Washinton, United States. Doi: 10.1016/S0735-1097(17)35051-9 [Oral Communication]
Web of Science FullText FullText_MUG

 

Silbernagel, G; Scharnagl, H; Kleber, ME; Grammer, TB; Delgado, G; Stojakovic, T; Gary, T; Ritsch, A; Zewinger, S; Speer, T; Landmesser, U; Marz, W J-SHAPED ASSOCIATION OF CIRCULATING APOLIPOPROTEIN C3 WITH CARDIOVASCULAR MORTALITY
ATHEROSCLEROSIS. 2017; 263: E89-E90.-85th Congress of the European-Atherosclerosis-Society (EAS); APR 23-26, 2017; Prague, CZECH REPUBLIC. Doi: 10.1016/j.atherosclerosis.2017.06.292 [Oral Communication]
Web of Science FullText FullText_MUG

 

Verheyen, N; Gaksch, M; Meinitzer, A; Grübler, M; Trummer, C; Schwetz, V; Pandis, M; Ablasser, K; Kolesnik, E; von Lewinski, D; Brussee, H; März, W; Tomaschitz, A; Pilz, S Amino acids kynurenine and quinolinic acid and target organ damage in hypertensive patients – novel insights from the Styrian hypertension study
http://www.esh2017.eu/abstract-book/. 2017; PP.01.06: -27th scientific meeting of the European Society of Hypertension (ESH); JUN 16-19, 2017; Mailand. [Poster]
FullText

 

Verheyen, N; Gaksch, M; Meinitzer, M; Grübler, M; Trummer, C; Schwetz, V; Ablasser, K; Kolesnik, E; von Lewinski, D; Brussee, H; März, W; Tomaschitz, A; Pilz, S Amino acid kynurenine and quinolinic acid and target organ damage in hypertensive patients - novel insights from the Styrian hypertension study
Wiener Klinische Wochenschrift, supplement 1/17. 2017; (129):S87-S87.-Jahrestagung der ÖKG; JUN 6-9, 2017; Salzburg, AUSTRIA. [Poster]

 

Zelzer, S; Enko, D; Meinitzer, A; Pilz, S; Tomaschitz, A; März, W Link between myeloperoxidase, asymmetric dimethylarginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients: cross-sectional findings from the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
Symposium: Biomarkers of the cardiovascular axis; JAN 19-20, 2017; Mannheim, GERMANY. 2017. [Poster]

 

Burgard, B; Schope, J; Ordonez-Mena, J; Pilz, S; Saternus, R; Reichrath, S; Schiekofer, C; Marz, W; Wagenpfeil, S; Vogt, T; Reichrath, J Does indoor tanning increase the risk for cutaneous melanoma? A meta-analysis and systematic review of the literature
EXP DERMATOL. 2016; 25(3):E33-E33.-43rd Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung-e-V (ADF); MAR 10-12, 2016; Vienna, AUSTRIA. [Poster]
Web of Science

 

Delgado, G; Siekmeier, R; Titze, L; Pilz, S; Marz, W; Kleber, M Vitamin D and 1,25-dihydroxycholecalciferol in smokers and nonsmokers of the Ludwigshafen Risk and Cardiovascular Health Study (LURIC)
WIEN KLIN WOCHENSCHR. .. 2016; 128(19-20):777-778. [Poster]
Web of Science

 

Koenig, W; Jaensch, A; Scharnagl, H; Mons, U; Breitling, LP; Brenner, H; Maerz, W; Rothenbacher, D Lipoprotein (Lp) (a) does not predict recurrent cardiovascular events in patients with stable coronary heart disease: 13-Year follow-up of the KAROLA study
EUR HEART J. 2016; 37: 404-404.-Congress of the European-Society-of-Cardiology (ESC); AUG 27-31, 2016; Rome, ITALY. [Poster]
Web of Science

 

Scharnagl, H; Kleber, ME; Grammer, TB; Stojakovic, T; Hoffmann, MM; Marz, W CV RISK FACTORS AND ATHEROSCLEROSIS II. APOLIPOPROTEIN CII AND CIII: PROGNOSTIC MARKERS OF CARDIOVASCULAR RISK?
ATHEROSCLEROSIS. 2016; 252: E217-E217.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA. Doi: 10.1016/j.atherosclerosis.2016.07.171 [Poster]
Web of Science FullText FullText_MUG

 

Scharnagl, H; Werner, C; Stojakovic, T; Marz, W; Laufs, U LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. ASSOCIATION OF THE POSTPRANDIAL CHYLOMICRON TRIGLYCERIDE/ APOB INDEX AND CARDIOVASCULAR EVENTS
ATHEROSCLEROSIS. 2016; 252: E99-E99.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA. Doi: 10.1016/j.atherosclerosis.2016.07.566 [Poster]
Web of Science FullText FullText_MUG

 

Schmidt, N; Marz, W; Grammer, T ESTABLISHMENT OF A NATIONWIDE CASCADE SCREENING PROGRAM AND REGISTER FOR FAMILIAL HYPERCHOLESTROLEMIA IN GERMANY-CARE HIGH
ATHEROSCLEROSIS. 2016; 252: E31-E32.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA. Doi: 10.1016/j.atherosclerosis.2016.07.335 [Keynote lecture]
Web of Science FullText FullText_MUG

 

Schmidt, N; Schmidt, B; Dressel, A; Gergei, I; Klotsche, J; Pieper, L; Scharnagel, H; Kleber, ME; Marz, W; Wittchen, HU; Grammer, T FAMILIAL HYPERCHOLESTEROLEMIA IN PRIMARY CARE IN GERMANY - DIABETES AND CARDIOVASCULAR RISK EVALUATION: TARGETS AND ESSENTIAL DATA FOR COMMITMENT OF TREATMENT (DETECT) STUDY
ATHEROSCLEROSIS. 2016; 252: E213-E213.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA. Doi: 10.1016/j.atherosclerosis.2016.07.160 [Keynote lecture]
Web of Science FullText FullText_MUG

 

Siekmeier, R; Delgado, G; Titze, L; Grammer, T; Pilz, S; Kleber, M; Marz, W Role of vitamin D deficiency in asthma bronchiale - an overview
WIEN KLIN WOCHENSCHR. .. 2016; 128(19-20):778-778. [Poster]
Web of Science

 

Verheyen, N; Grubler, M; Fahrleitner-Pammer, A; Pilz, S; Tomaschitz, A; Marz, W Plasma parathyroid hormone is independently associated with atrial fibrillation - Insights from the LURIC study
WIEN KLIN WOCHENSCHR. 2016; 128: S307-S308. [Poster]
Web of Science

 

Verheyen, N; Meinitzer, A; Ablasser, K; Fahrleitner-Pammer, A; Brussee, H; Pilz, S; Tomaschitz, A Serum kynurenine, quinolinic acid and cardiac stiffness parameters: the eplerenone in primary hyperparathyroidism study
WIEN KLIN WOCHENSCHR. 2016; 128: S308-S308. [Poster]
Web of Science

 

Voelkl, J; Alesutan, I; Feger, M; Tuffaha, R; Castor, T; Musculus, K; Buehling, SS; Heine, CL; Kuro-O, M; Pieske, B; Schmidt, K; Tomaschitz, A; Maerz, W; Pilz, S; Meinitzer, A; Lang, F Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells and vascular calcification by homoarginine
ACTA PHYSIOL. 2016; 216: [Poster]
Web of Science

 

Werner, C; Stojakovic, T; Maerz, W; Scharnagl, H; Laufs, U Association of the postprandial chylomicron triglyceride/apoB index and cardiovascular events
EUR HEART J. 2016; 37: 218-218.-Congress of the European-Society-of-Cardiology (ESC); AUG 27-31, 2016; Rome, ITALY. [Poster]
Web of Science

 

Wetzel, J; Pilz, S; Gruebler, M; Fahrleitner-Pammer, A; Dimai, HP; Von Lewinski, D; Kolesnik, E; Perl, S; Weinrauch, V; Maerz, W; Belyavskiy, E; Pieske, B; Brussee, H; Tomaschitz, A; Verheyen, N Parathyroid hormone is independently associated with systolic blood pressure, pulse wave velocity and left ventricular mass index in patients with primary hyperparathyroidism
EUR HEART J. 2016; 37: 417-417.-Congress of the European-Society-of-Cardiology (ESC); AUG 27-31, 2016; Rome, ITALY. [Poster]
Web of Science

 

Woitas, R; Scharnagl, H; Kleber, ME; Delgado, GE; Grammer, TB; Pichler, M; Kramer, BK; Marz, W; Stojakovic, T IMPACT OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN AND NEUTROPHIL COUNTS IN THE LUDWIGSHAFEN RISK AND CARDIOVASCULART HEALTH STUDY
ATHEROSCLEROSIS. 2016; 252: E67-E67.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA. Doi: 10.1016/j.atherosclerosis.2016.07.455 [Poster]
Web of Science FullText FullText_MUG

 

Zelzer, S; Enko, D; Meinitzer, A; Pilz, S; Tomaschitz A; März, W Link between myeloperoxidase, asymmetric dimethylarginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients: Cross-sectional findings from the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
SYMPOSIUM: BIOMARKERS OF THE CARDIORENAL AXIS; JAN 22-23, 2016; Würzburg, GERMANY. 2016. [Poster]
FullText

 

Zewinger, S; Kleber, ME; Triem, S; Lehmann, M; Lepper, PM; Silbernagel, G; Scharnagl, H; Ritsch, A; Laufs, U; Fliser, D; Marz, W; Speer, T HIGH-DENSITY LIPOPROTEIN - SYMMETRIC DIMETHYLARGININE - A CKD-SPECIFIC ASSOCIATION PROMOTING PREMATURE CARDIOVASCULAR DISEASE
NEPHROL DIAL TRANSPL. 2016; 31: 181-181.-53rd ERA-EDTA Congress; MAY 21-24, 2016; Vienna, AUSTRIA. [Poster]
Web of Science

 

de Moissl, GD; Siekmeier, R; Kramer, BK; Marz, W; Kleber, M Role of Factor-V-Tolerate and Prothrombinvariante as Signal to the Prediction of Mortality in the Ludwigshafen Risk and Cardiovascular Health Study(LURIC)
WIEN KLIN WOCHENSCHR. 2015; 127: S36-S36. [Poster]
Web of Science

 

Dieplinger, H; Melmer, A; Kleber, M; Scharnagl, H; Marz, W AFAMIN - A NOVEL MARKER FOR THE PRESENCE AND INCIDENCE OF METABOLIC SYNDROME AND RELATED DISEASES
ATHEROSCLEROSIS. 83rd Congress of the European-Atherosclerosis-Society (EAS). 2015; 241(1):E174-E174.-83rd Congress of the European-Atherosclerosis-Society (EAS); MAR 22-25, 2015; Glasgow, SCOTLAND. Doi: 10.1016/j.atherosclerosis.2015.04.882 [Poster]
Web of Science FullText FullText_MUG

 

Koller, L; Kleber, ME; Brandenburg, VM; Goliasch, G; Scharnagl, H; Grammer, TB; Tomaschitz, A; Huelsmann, M; Maerz, W; Niessner, A Fibroblast growth factor 23 is an independent and specific predictor of mortality in patients with heart failure and reduced ejection fraction
EUR HEART J. 2015; 36: 1201-1201.-Congress of the European-Society-of-Cardiology (ESC); AUG 29-SEP 02, 2015; London, ENGLAND. [Keynote lecture]
Web of Science

 

Ritsch, A; Duerr, A; Kahler, P; Stojakovic, T; Silbernagel, G; Scharnagl, H; Kleber, ME; Marz, W HDL CHOLESTEROL EFFLUX CAPACITY AND CARDIOVASCULAR MORTALITY.
ATHEROSCLEROSIS. 2015; 241(1):E28-E28.-83rd Congress of the European-Atherosclerosis-Society (EAS); MAR 22-25, 2015; Glasgow, SCOTLAND. Doi: 10.1016/j.atherosclerosis.2015.04.106 [Oral Communication]
Web of Science FullText FullText_MUG

 

Saternus, R; Graber, S; Pilz, S; Kleber, M; Marz, W; Vogt, T; Reichrath, J GENETIC VARIANTS (SNPS) OF GENES INVOLVED IN SKIN PIGMENTATION ARE ASSOCIATED WITH 25(OH)D SERUM CONCENTRATION
ANTICANCER RES. 2015; 35(6):3606-3606. [Oral Communication]
Web of Science

 

Scharnagl, H; Stojakovic, T; Dieplinger, B; Dieplinger, H; Kostner, G; März, W Quantitative Bestimmung von Lipoprotein(a): ein Vergleich kommerzieller Assays.
45. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 26-28, 2015; Maikammer, GERMANY. 2015. [Oral Communication]

 

Silbernagel G, Pagel P, Pfahlert V, Genser B, Scharnagl H, Kleber ME, Delgado G, Ritsch A, Grammer TB, Baumgartner I, Koenig W, März W High Density Lipoprotein Particles Predict All-cause and Cardiovascular Mortality
Circulation. 2015; (132): A1812--American Heart Association Scientific Sessions; Nov 7-11; Orlando, Florida, United States. [Poster]
FullText

 

Werner, C; Stojakovic, T; März, W; Scharnagl, H; Laufs, U Das postprandiale Chylomikronen-Triglyzerid/ApoB-Verhältnis ist ein potentieller Prädiktor für kardiovaskuläre Ereignisse in Statin-behandelten Patienten mit stabiler koronarer Herzkrankheit.
45. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 26-28, 2015; Maikammer, GERMANY. 2015. [Oral Communication]

 

Woitas, R; Scharnagl, H; Kleber, ME; Grammer, TB; Pichler, M; März, W; Stojakovic, T Impact of neutrophil gelatinase-associated lipocalin and neutrophil counts in the Ludwigshafen Risk and Cardiovascular Health Study.
45. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 26-28, 2015; Maikammer, GERMANY. 2015. [Oral Communication]

 

Zewinger, S; Speer, T; Drechsler, C; Kleber, ME; Dressel, A; Riffel, J; Lehmann, M; Kopecky, C; Saemann, MD; Lepper, PM; Silbernagel, G; Scharnagl, H; Ritsch, A; Laufs, U; Wanner, C; Fliser, D; Marz, W SERUM AMYLOID A (SAA) AND HIGH DENSITY LIPOPROTEINS (HDL) INTERACTION AND CARDIOVASCULAR RISK IN RENAL PATIENTS
NEPHROL DIAL TRANSPL. 2015; 30: -52nd Congress of the European-Renal-Association-European-Dialysis-and-Transplant-Assocation; MAY 28-31, 2015; London, ENGLAND. Doi: 10.1093/ndt/gfv135.5 [Poster]
Web of Science FullText FullText_MUG

 

M; Drechsler, C; Philstrom, H; Meinitzer, A; Pilz, S; Tomaschitz, A; Abedini, S; Fellstrom, B; Jardine, A; Wanner, C; Maerz, W; Holdaas, H; HOMOARGININE AND CLINICAL OUTCOMES IN RENAL TRANSPLANT RECIPIENTS: RESULTS FROM THE ALERT STUDY
Nephrol Dial Transplant. . 2014; 29 Suppl 3: iii539-iii566-iii539-iii566. Doi: 10.1093/ndt/gfu180 [Poster]
FullText FullText_MUG

 

Delgado, G; Drechsler, C; Wanner, C; Blouin, K; Pilz, S; Tomaschitz, A; Kleber, ME; Willmes, C; Krane, V; Marz, W; Ritz, E; Van Gilst, WH; Van der Harst, P; De Boer, RA GALECTIN-3 AND ADVERSE OUTCOMES IN CHRONIC KIDNEY DISEASE - RESULTS FROM THE LURIC AND THE 4D STUDY
NEPHROL DIAL TRANSPL. 2014; 29: 120-120.-51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA); MAY 31-JUN 03, 2014; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Delgado, G; Kleber, ME; Grammer, TB; Kraemer, BK; Maerz, W; Scharnagl, H ALTERATIONS OF LIPOPROTEIN CONSTITUTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE SHOWED NO EVIDENCE FOR AN INCREASE OF SMALL DENSE LDL - RESULTS FROM THE LURIC STUDY
NEPHROL DIAL TRANSPL. 2014; 29: 156-156.-51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA); MAY 31-JUN 03, 2014; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Delgado, G; Siekmeier, R; Grammer, T; Bohm, B; Marz, W; Kleber, M Plasma fibrinolysis parameters in smokers and nonsmokers of the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
WIEN KLIN WOCHENSCHR. 2014; 126(19-20):682-682. [Poster]
Web of Science

 

Drechsler, C; Philstrom, H; Meinitzer, A; Pilz, S; Tomaschitz, A; Abedini, S; Fellstrom, B; Jardine, A; Wanner, C; Maerz, W; Holdaas, H HOMOARGININE AND CLINICAL OUTCOMES IN RENAL TRANSPLANT RECIPIENTS: RESULTS FROM THE ALERT STUDY
NEPHROL DIAL TRANSPL. 2014; 29: 539-539.-51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA); MAY 31-JUN 03, 2014; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Fauler, G; Silbernagel, G; Genser, B; Krane, V; Drechsler, C; Scharnagl, H; Ritz, E; Wanner, C; Marz, W CHOLESTEROL ABSORPTION PREDICTS THE EFFECTIVENESS OF ATORVASTATIN FOR PREVENTING CARDIOVASCULAR END POINTS IN DIABETIC HEMODIALYSIS PATIENTS
ATHEROSCLEROSIS. 2014; 235(2):E74-E74.-82nd Congress of the European-Atherosclerosis-Society (EAS); MAY 31-JUN 03, 2014; Madrid, SPAIN. Doi: 10.1016/j.atherosclerosis.2014.05.191 [Poster]
Web of Science FullText FullText_MUG

 

Goliasch, G; Kleber, M; Grammer, TB; Pilz, S; Tomaschitz, A; Silbernagel, G; Maurer, G; Marz, W; Alexander, N EVOLVING BIOMARKERS IMPROVE PREDICTION OF LONG-TERM MORTALITY IN PATIENTS WITH STABLE CAD: THE BIO-VILCAD SCORE
J AM COLL CARDIOL. 2014; 63(12):A1390-A1390. Doi: 10.1016/S0735-1097(14)61390-5 [Poster]
Web of Science FullText FullText_MUG

 

Grammer, TB; Kleber, M; Maerz, W; Silbernagel, G; Siekmeier, R; Pilz, S; Tomaschitz, A; Konig, W; Scharnagl, H Particle Diameter in the Low Density Lipoprotein as Mortality Factor- Results from Ludwigshafen Risk and Cardiovascular Health Study(LURIC)
WIEN KLIN WOCHENSCHR. 2014; 126: S133-S134.
Web of Science

 

Grubler, M; Gaksch, M; Verheyen, N; J Schmid, J; Wetzel, J; Pieske, B; Pilz, S; Tomaschitz, A; Maerz W Aldosterone is associated with parathyroid hormone levels in patients with acute coronary syndrome.
Eur Heart J Acute Cardiovasc Care. 2014; 3(2):173-173.-ACCA Congress; Oct 18-20, 2014; Geneva, Switzerland. [Poster]
FullText

 

Grubler, M; Gaksch, M; Verheyen, N; Schmid, J; Wetzel, J; Pieske, B; Pilz, S; Tomaschitz, A; Maerz W Plasma aldosterone concentration and long term fatal coronary events.
Eur Heart J Acute Cardiovasc Care. 2014; 3(2):207-207.-ACCA Congress; Oct 18-20, 2014; Geneva, Switzerland. [Poster]
FullText

 

Grubler, MR; Verheyen, N; Gaksch, M; Kienreich, K; Oberreither, E; Schmid, J; Pieske, B; Tomaschitz, A; Pilz, S; Maerz, W Parathyroid hormone is associated with cardiovascular mortality in patients with acute coronary syndrome
EUR HEART J. 2014; 35: 1157-1157.-Congress of the European-Society-of-Cardiology (ESC); AUG 30-SEP 03, 2014; Barcelona, SPAIN. [Poster]
Web of Science

 

Heisterkamp, M; Titze, S; Lorenzen, J; Eckardt, KU; Koettgen, A; Kielstein, JT; Bouquegneau, A; Vidal-Petiot, E; Vrtovsnik, F; Cavalier, E; Krzesinski, JM; Flamant, M; Delanaye, P; Anguiano, L; Riera, M; Pascual, J; Barrios, C; Betriu, A; Valdivielso, JM; Fernández, E; Soler, MJ; Denys, MA; Viaene, A; Goessaert, AS; Delanghe, J; Everaert, K; Kim, YS; Choi, MJ; Deok, JY; Kim, SG; Bevc, S; Hojs, N; Hojs, R; Ekart, R; Gorenjak, M; Puklavec, L; Bevc, S; Hojs, N; Hojs, R; Ekart, R; Gorenjak, M; Puklavec, L; Piskunowicz, M; Hofmann, L; Zürcher, E; Bassi, I; Zweiacker, C; Stuber, M; Narkiewicz, K; Vogt, B; Burnier, M; Pruijm, M; Rusu, E; Zilisteanu, D; Atasie, T; Circiumaru, A; Carstea, F; Ecobici, M; Rosca, M; Tanase, C; Mihai, S; Voiculescu, M; Kim, YS; Jeon, YD; Choi, MJ; Kim, SG; Polenakovic, M; Pop-Jordanova, N; Hung, SC; Tarng, DC; Tuta, L; Stanigut, A; Mesiano, P; Rollino, C; Ferro, M; Beltrame, G; Massara, C; Quattrocchio, G; Borca, M; Bazzan, M; Roccatello, D; Maksudova, A; Urasaeva, LI; Khalfina, TN; Zilisteanu, D; Rusu, E; Atasie, T; Ecobici, M; Circiumaru, A; Carstea, F; Rosca, M; Tanase, C; Mihai, S; Voiculescu, M; Tekce, H; Kin Tekce, B; Aktas, G; Alcelik, A; Sengul, E; Lindic, J; Purg, D; Skamen, J; Krsnik, M; Skoberne, A; Pajek, J; Kveder, R; Bren, A; Kovac, D; Kin Tekce, B; Tekce, H; Aktas, G; Delgado, G; Drechsler, C; Wanner, C; Blouin, K; Pilz, S; Tomaschitz, A; Kleber, ME; Willmes, C; Krane, V; März, W; Ritz, E; Van Gilst, WH; Van Der Harst, P; De Boer, RA; Scholze, A; Petersen, L; Hocher, B; Rasmussen, LM; Tepel, M; De Paula, EA; Vanelli, CP; Caminhas, MS; Soares, BC; Bassoli, FA; Da Costa, DM; Lanna, CM; Galil, AG; Colugnati, FA; Costa, MB; Bastos, MG; De Paula, RB; Santoro, D; Zappulla, Z; Alibrandi, A; Tomasello Andulajevic, M; Licari, M; Baldari, S; Buemi, M; Cernaro, V; Campennì, A; Pallet, N; Chauvet, S; Levi, C; Meas-Yedid, V; Beaune, P; Thevet, E; Karras, A; Santos, S; Malheiro, J; Campos, A; Pedroso, S; Santos, J; Cabrita, A; Mayor, MM; Ayala, R; Ramos, C; Franco, S; Guillén, R; Kim, JS; Yang, JW; Han, BG; Choi, SO; Tudor, MN; Navajas Martinez, MF; Vaduva, C; Maria, DT; Mota, E; Clari, R; Mongilardi, E; Vigotti, FN; Consiglio, V; Scognamiglio, S; Nazha, M; Roggero, S; Piga, A; Piccoli, G; Mukhopadhyay, P; Patar, K; Chaterjee, N; Ganguly, K Ckd lab methods, progression and risk factors 1.
Nephrol Dial Transplant. . 2014; 29 Suppl 3: iii114-iii123-iii114-iii123. Doi: 10.1093/ndt/gfu145 [Poster]
FullText FullText_MUG

 

Kleber, ME; Delgado, G; Grammer, TB; Silbernagel, G; Kraemer, BK; Maerz, W ARE URIC ACIDS SERUM LEVELS CAUSALLY INVOLVED IN THE DEVELOPMENT OF CORONARY ARTERY DISEASE, CARDIOVASCULAR MORTALITY OR SUDDEN CARDIAC DEATH? A GENETIC STUDY USING THE MENDELIAN RANDOMISATION APPROACH
NEPHROL DIAL TRANSPL. 2014; 29: 341-341.-51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA); MAY 31-JUN 03, 2014; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Koller, L; Kleber, ME; Goliasch, G; Sulzgruber, P; Scharnagl, H; Silbernagel, G; Grammer, T; Pilz, S; Maerz, W; Niessner, A C-reactive protein and NT-proBNP for predicting mortality in patients with heart failure with preserved ejection fraction
EUR HEART J. 2014; 35: 871-871.-Congress of the European-Society-of-Cardiology (ESC); AUG 30-SEP 03, 2014; Barcelona, SPAIN. [Poster]
Web of Science

 

Kopecky, CM; Genser, B; Maerz, W; Wanner, C; Saemann, MD; Weichhart, T HDL PROTEINS AS PREDICTORS OF CARDIOVASCULAR RISK AND MORTALITY IN DIABETIC PATIENTS ON HEMODIALYSIS
NEPHROL DIAL TRANSPL. 2014; 29: 238-238.-51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA); MAY 31-JUN 03, 2014; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Marz, W; Pilz, S VITAMIN D IN PREVENTIVE MEDICINE
ANTICANCER RES. 2014; 34(4):2047-2048. [Oral Communication]
Web of Science

 

Meinitzer, A; Faustmann, G; Grabher, J; Zelzer, S; Obermayer-Pietsch, B; Tiran, B; Pilz, S;Truschnig-Wilders, M; März, W; Roob, JM; Winklhofer-Roob, BM CHANGES IN ASYMMETRIC DIMETHYLARGININE, A CIRCULATING NITRIC OXIDE RELEASING FACTOR, AS A BIOMARKER OF ENDOTHELIAL STATUS DURING THE MENSTRUAL CYCLE.
Journal Clinical Chemistry and Laboratory Medicine (CCLM), Official Journal of the European Federation of Clinical Chemistry and Laboratory Medicine. 2014; 52(7):267-267.-IFCC WorldLab Istanbul 2014; June 22-26, 2014; Istanbul, TURKEY. [Poster]
FullText

 

Murr, C; Grammer, T; Kleber, M; Meinitzer, A; Marz, W; Fuchs, D. LOW SERUM TRYPTOPHAN PREDICTS HIGHER MORTALITY IN CARDIOVASCULAR DISEASE.
ATHEROSCLEROSIS. 2014; 235(2):E88-E88.-82nd Congress of the European-Atherosclerosis-Society (EAS).; MAY 31-JUN 03, 2014; Madrid, SPAIN. Doi: 10.1016/j.atherosclerosis.2014.05.232 [Oral Communication]
Web of Science FullText FullText_MUG

 

Pihlstrom, H; Dahle, D; Mjoen, G; Pilz, S; Maerz, W; Holme, I; Fellstrom, B; Jardine, A; Holdaas, H Hyperparathyroidism in Stable Renal Transplant Recipients Is Associated With All-Cause Mortality and Renal Graft Loss
AM J TRANSPLANT. 2014; 14: 126-126.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA. [Poster]
Web of Science

 

Pihlstrom, H; Dahle, D; Mjoen, G; Pilz, S; Maerz, W; Holme, I; Fellstrom, B; Jardine, A; Holdaas, H; Hyperparathyroidism in Stable Renal Transplant Recipients Is Associated With All-Cause Mortality and Renal Graft Loss.
TRANSPLANTATION. 2014; 98: 126-126.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA. Doi: 10.1097/00007890-201407151-00388 [Poster]
Web of Science FullText FullText_MUG

 

Pihlstrom, H; Mjoen, G; Dahle, D; Pilz, S; Midtvedt, K; Maerz, W; Abedini, S; Holme, I; Fellstrom, B; Holdaas, H Symmetric Dimethylarginine as Predictor of Graft Loss and All-Cause Mortality in Renal Transplant Recipients
AM J TRANSPLANT. 2014; 14: 102-102.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA. [Poster]
Web of Science

 

Pihlstrom, H; Mjoen, G; Dahle, D; Pilz, S; Midtvedt, K; Maerz, W; Abedini, S; Holme, I; Fellstrom, B; Holdaas, H; Symmetric Dimethylarginine as Predictor of Graft Loss and All-Cause Mortality in Renal Transplant Recipients.
TRANSPLANTATION. 2014; 98: 102-102.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA. Doi: 10.1097/00007890-201407151-00316 [Poster]
Web of Science FullText FullText_MUG

 

Rinde, H; Genser, B; Sonntag, D; Kleber, ME; Stojakovic, T; Scharnagl, H; Maerz, W COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF RISK STRATIFICATION OF PATIENTS WITH MODERATE RISK OF CARDIOVASCULAR EVENTS USING LP-PLA2 TESTING
VALUE HEALTH. 2014; 17(7): A481-A481. Doi: 10.1016/j.jval.2014.08.1393
Web of Science FullText FullText_MUG

 

Saternus, R; Graber, S; Pilz, S; Kleber, M; Marz, W; Vogt, T; Reichrath, J GENETIC VARIANTS (SNPS) OF GENES INVOLVED IN SKIN PIGMENTATION ARE ASSOCIATED WITH 25(OH)D SERUM CONCENTRATION
ANTICANCER RES. 2014; 34(4):2056-2056. [Poster]
Web of Science

 

Scharnagl, H; Grammer, TB; Kleber, ME; Stojakovic, T; März, W LDL triglycerides, but not LDL cholesterol predict mortality in the LURIC study.
Symposium Biomarker und Nierenerkrankungen, 15 Jahre 4D-Studie; JAN 17-18, 2014; Würzburg, GERMANY. 2014. [Poster]

 

Scharnagl, H; Hoffmann, MM; Kleber, ME; Grammer, TB; Stojakovic, T; März, W Apolipoprotein CII und CIII: prognostische Marker für das kardiovaskuläre Risiko?
44. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 27-29, 2014; Maikammer, GERMANY. 2014. [Oral Communication]

 

Scharnagl, H; Kleber, ME; Stojakovic, T; Grammer, TB; März, W; Brandenburg, VM Fibroblast growth factor 23 (FGF-23) and mortality (The Ludwigshafen Risk and Cardiovascular Health Study).
21. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); MAY 9-10, 2014; St. Gilgen, AUSTRIA. 2014. [Oral Communication]

 

Scharnagl, H; Stojakovic, T; Kleber, ME; Grammer, TB; März, W Low density lipoprotein triglycerides and mortality: The Ludwigshafen Risk and Cardiovascular Health Study.
The 2nd World Congress of Clinical Lipidology; DEC 5-7, 2014; Vienna, AUSTRIA. 2014. [Oral Communication]

 

Scharnagl, H; Weihrauch, G; Grammer, TB; Kleber, ME; Stojakovic, T; März, W Interleukin-6 out-performs CRP as a predictor of long-term mortality in the LURIC study.
Symposium Biomarker und Nierenerkrankungen, 15 Jahre 4D-Studie; JAN 17-18, 2014; Würzburg, GERMANY. 2014. [Poster]

 

Stojakovic, T; Scharnagl, H; Winkelmann, BR; Boehm, BO; März, W Ischemia Modified Albumin (IMA): diagnostic potential value beyond cardiac troponins.
Symposium Biomarker und Nierenerkrankungen, 15 Jahre 4D-Studie; JAN 17-18, 2014; Würzburg, GERMANY. 2014. [Poster]

 

Tomaschitz, A; Verheyen, N; Gaksch, M; Grübler, MR; Wetzel, J; Belyavskyi, E; Colantonio, C; Kraigher-Krainer, E; März, W; Grammer, T; Meinitzer, A; Rus-Machan, J; Fahrleitner-Pammer, A; Pieske, B; Pilz, S Ambulatory Blood Pressure Monitoring and Kynurenic Acid in Female Patients with Primary Hyperparathyroidism - the EPATH Study.
Journal of Hypertension. 2014; -ESH/ISH Joint Meeting; June 13-16, 2014; Athens, Greece. [Oral Communication]

 

Tomaschitz, A; Verheyen, N; Gaksch, M; Grübler, MR; Wetzel, J; Belyavskyi, E; Colantonio, C; Kraigher-Krainer, E; März, W; Grammer, T; Meinitzer, A; Rus-Machan, J; Fahrleitner-Pammer, A;Pieske, B; Pilz, S Associations of Tryptophan Metabolism with Systolic and Diastolic Left Ventricular Function in Patients with Primary Hyperparathyroidism
Journal of Hypertension. 2014; -ESH/ISH Joint Meeting; June 13-16, 2014; Athens, Greece. [Oral Communication]

 

Verheyen, N; Gaksch, M; Grogorenz, J; Kienreich, K; Grübler, MR; Schmid, J; Wetzel, J; Belyavskiy, E; Colantonio, C; Kraigher-Krainer, E; Maerz, W; Meinitzer, A; Fahrleitner-Pammer, A; Pieske, B; Pilz, S; Tomaschitz, A Differences In 24-Hours Ambulatory Blood Pressure Readings Between Hypertensives With And Without Primary Hyperparathyroidism – A Case Control Study
Journal of Hypertension. 2014; -ESH/ISH Joint Meeting; June 13-16, 2014; Athens, Greece. [Poster]

 

Verheyen, N; Tomaschitz, A; Pilz, S; Fahrleitner-Pammer, A; Gaksch, M; Grübler, M; Belyavskiy; Kraigher-Krainer, E; Pieske, B;März, W The Relationship Between the Aldosterone-to-Renin Ratio and Markers of Bone Turnover - the LURIC Study
Putting the A back into RAAS satellite meeting; June 10-12, 2014; Thira, Santorini, Greece. 2014. [Oral Communication]

 

Woitas, R; Scharnagl, H; Kleber, ME; Grammer, TB; Meinitzer, A; Silbernagel, G; Pilz, S; Tomaschitz, A; März, W, Stojakovic, T NGAL and mortality in the LURIC study.
Symposium Biomarker und Nierenerkrankungen, 15 Jahre 4D-Studie; JAN 17-18, 2014; Würzburg, GERMANY. 2014. [Poster]

 

Zewinger, S; Speer, T; Kleber, ME; Scharnagl, H; Woitas, R; Pfahler, K; Seiler, S; Heine, GH; Lepper, PM; Marz, W; Silbernagel, G; Fliser, D HDL CHOLESTEROL IS NOT VASOPROTECTIVE IN PATIENTS WITH IMPAIRED RENAL FUNCTION
NEPHROL DIAL TRANSPL. 2014; 29: 133-133.-51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA); MAY 31-JUN 03, 2014; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Delgado, G; Kleber, M; Siekmeier, R; Marz, W; Scharnagl, H; Enrichment of triglyceride-rich Particles with no Evidence of small dense LDL (sdLDL) in LURIC Patients with impaired Renal Function.
WIEN KLIN WOCHENSCHR. . 2013; 125(17-18):569-570. [Poster]
Web of Science

 

Delgado, G; Siekmeier, R; Grammer, T; Scharnagl, H; Marz, W; Highly sensitive CRP (hsCRP) and Myeloperoxidase (MPO) in Smokers and Non-smokers in the Ludwigshafen Risk and Cardiovascular Health Study (LURIC).
WIEN KLIN WOCHENSCHR. 2013; 125(17-18):567-568. [Poster]
Web of Science

 

Dieplinger, B; Egger, M; Haltmayer, M; Kleber, ME; Scharnagl, H; Silbernagel, G; Grammer, TB; Maerz, W; Mueller, T; Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease.
EUR HEART J. 2013; 34: 504-504.-Congress of the European-Society-of-Cardiology (ESC); AUG 31-SEP 04, 2013; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Drechsler, C; Wanner, C; Blouin, K; Pilz, S; Tomaschitz, A; Krane, V; Marz, W; Ritz, E; van der Harst, P; de Boer, R; THE NOVEL FIBROSIS MARKER GALECTIN 3 ASSOCIATES WITH INFECTIOUS DEATHS, ALL-CAUSE MORTALITY AND CARDIOVASCULAR EVENTS IN HEMODIALYSIS PATIENTS.
NEPHROL DIALYSIS TRANSPLANT. 2013; 28: 489-489.-50th European-Renal-Association - European-Dialysis-and-Transplant-Association Congress; MAY 18-21, 2013; Istanbul, TURKEY. [Oral Communication]
Web of Science

 

Gaksch, M; Grübler, MR; Kienreich, K; Tomaschitz, A; Ritz, E; Verheyen, N; Fahrleitner-Pammer, A; Schmid, J; Pieske, B; März, W; Pieber, TR; Pilz, S; Aldosterone is associated with parathyroid hormone in patients with arterial hypertension: The Styrian Hypertension Study
EYES (European Young Endocrine Scientists) 1st meeting; OCT 11-13, 2013; Rotterdam, the Netherlands. 2013. [Oral Communication]
FullText

 

Gaksch, M; Pilz, S; Piecha, G; Ritz, E; Meinitzer, A; Pieske, B; Wiecek, A; Haas, J; Kienreich, K; März, W; Verheyen, N; Fahrleitner-Pammer, A; Kraigher-Krainer, E; Drechsler, C; Tomaschitz, A Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications - The Graz Endocrine Causes of Hypertension (GECOH) Study
PIPA 3 (Progress in Primary Aldosteronism); JUL 3-5, 2013; Munich, Germany. 2013. [Oral Communication]
FullText

 

Genser, B; Silbernagel, G; De Backer, G; Bruckert, E; Carmena, R; Chapman, MJ; Deanfield, J; Descamps, OS; Rietzschel, ER; Maerz, W PLANT STEROLS AND CARDIOVASCULAR DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
CARDIOLOGY. 2013; 125: 53-53.
Web of Science

 

Goliasch, G; Kleber, M; Grammer, T; Pilz, S; Tomaschitz, A; Silbernagel, G; Maurer, G; Marz, W; Niessner, A Evolving biomarkers improve prediction of long-term mortality in patients with stable CAD: the BIO-VILCAD score
WIEN KLIN WOCHENSCHR. .. 2013; 125: S84-S85. [Poster]
Web of Science

 

Goliasch, G; Kleber, M; Grammer, T; Pilz, S; Tomaschitz, A; Silbernagel, G; Maurer, G; März, W; Niessner, A Evolving biomarkers improve prediction of long-term mortality in patients with stable CAD – The BIO-VILCAD Score
http://www.atcardio.at/fileadmin/images/Kardio_Salzburg_2013_HP_Web_02.pdf. 2013; -Jahrestagung der ÖKG 2013; JUN 5-8, 2013; Salzburg, AUSTRIA. [Poster]

 

Goliasch, G; Silbernagel, G; Kleber, M; Grammer, T; Pilz, S; Tomaschitz, A; Maurer, G; Niessner, A; Maerz, W; Refining long-term prediction of cardiovascular risk in diabetes.
EUR HEART J. 2013; 34: 351-352.-Congress of the European-Society-of-Cardiology (ESC); AUG 31-SEP 04, 2013; Amsterdam, NETHERLANDS. [Oral Communication]
Web of Science

 

Grubler, MR; Verheyen, N; Pilz, S; Kienreich, K; Gaksch, M; Schmid, J; Rus-Machan, J; Fahrleitner-Pammer, A; Kraigher-Krainer, E; Pieske, B; Marz, W; Tomaschitz, A Is Resting Heart Rate Really Associated With Cardiovascular Mortality?
CIRCULATION. 2013; 128(22): [Poster]
Web of Science FullText

 

Grubler, MR; Verheyen, N; Tomaschitz, A; Kienreich, K; Gaksch, M; Bersuch, LA; Fahrleitner-Pammer, A; Schmid, J; Marz, W; Pieske, B; Pilz, S Nocturnal Diastolic Blood Pressure is Associated With 24 Hour Urinary Albumin in Essential Hypertensive Patients
CIRCULATION. 2013; 128(22): [Oral Communication]
Web of Science FullText

 

Lerchbaum, E; Pilz, S; Grammer, TB; Boehm, BO; Stojakovic, T; Obermayer-Pietsch, B; März, W Prognostic value of the fatty liver index.
Symposium Biomarker und Gefäßerkrankungen, 15 Jahre LURIC-Studie; JAN 18-19, 2013; Mannheim, GERMANY. 2013. [Poster]

 

Pilz, S; Teerlink, T; Scheffer PG; Meinitzer, A; Rutters, F; Tomaschitz, A; Drechsler, C; Kienreich, K; Nijpels, G; Stehouwer, CD; März, W; Dekker, JM Homoarginine and mortality in an older population: the Hoorn Study
Abstractband. 2013; -2013 Diet and Optimum Health Conference; MAY 15-18, 2013; Corvallis, USA. [Poster]

 

Saternus, R; Graber, S; Pilz, S; Kleber, M; Marz, W; Vogt, T; Reichrath, J; Genetic variants (SNPs) of genes involved in skin pigmentation are associated with 25(OH)D serum concentration.
EXP DERMATOL. 2013; 22(3):E16-E16.-40th Annual Meeting of the Association-of-Dermatological-Research; MAR 14-16, 2013; Dessau, GERMANY. [Poster]
Web of Science

 

Scharnagl, H; Grammer, TB; Kleber ME; Stojakovic, T; Kassner, U; Steinhagen-Thiessen, E; März, W Prevalence and characteristics of autosomal dominant hypercholesterolemia in persons scheduled for angiography.
Symposium Biomarker und Gefäßerkrankungen, 15 Jahre LURIC-Studie; JAN 18-19, 2013; Mannheim, GERMANY. 2013. [Poster]

 

Stojakovic, T; Scharnagl, H; Winkelmann, BR; Boehm, BO; Maerz, W Ischemia modified albumin: diagnostic potential value beyond cardiac troponins.
EUR HEART J. 2013; 34: 1020-1020.-Congress of the European-Society-of-Cardiology (ESC); AUG 31-SEP 04, 2013; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Stojakovic, T; Scharnagl, H; Winkelmann, BR; Boehm, BO; März, W Ischemia Modified Albumin (IMA): diagnostic potential value beyond cardiac troponins.
Symposium Biomarker und Gefäßerkrankungen, 15 Jahre LURIC-Studie; JAN 18-19, 2013; Mannheim, GERMANY. 2013. [Poster]

 

Tomaschitz, A; Grammer, T; Pilz, S; Meinitzer, A; Rus-Machan, J; Pieske, B; Toplak, H; Kraigher-Krainer, E; März, W. Amino acid profile, glucose homeostasis and risk of cardiovascular death in type 2 diabetes
http://www.oedg.org/pdf/1311_JT_Hauptprogramm.pdf. 2013; -41. Jahrestagung der ÖDG; NOV 21-23, 2013; Salzburg, AUSTRIA. [Oral Communication]

 

Tomaschitz, A; Grammer, T; Verheyen, N; Pilz, S; Rus-Machan, J; Meinitzer, A; Ritz, E; Pieske, P; Kienreich, K; Fahrleitner- Pammer, A; Kraigher-Krainer, E; Boehm, B.O.; März. W Amino acid status and risk of heart failure death
http://www.atcardio.at/fileadmin/images/Kardio_Salzburg_2013_HP_Web_02.pdf. 2013; -Jahrestagung der ÖKG 2013 ; JUN 5-8, 2013; Salzburg, AUSTRIA. [Poster]

 

Tomaschitz, A; Meinitzer, A; Pieske, B; März, W; Fahrleitner-Pammer, A; Grammer, T; Kraigher-Krainer, E; Toplak, H; Pilz, S. Association of Tryptophan Metabolism with Metabolic Traits in Hypertensive Patients
http://www.oedg.org/pdf/1311_JT_Hauptprogramm.pdf. 2013; -41. Jahrestagung der ÖDG; 21.-23. November 2013; Salburg, AUSTRIA. [Poster]

 

Verheyen, N; Grubler, M; Pilz, S; Kienreich, K; Gaksch, M; Schmid, J; Bersuch, LA; Pieske, B; Kraigher-Krainer, E; Fahrleitner-Pammer, A; Boehm, BO; Marz, W; Tomaschitz, A Serum Parathyroid Hormone is Independently Associated With Atrial Fibrillation: Insights From the LURIC Study
CIRCULATION. 2013; 128(22): [Poster]
Web of Science FullText

 

Wallner-Liebmann, S; Siekmeier, R; Grammer, T; Mangge, H; Marz, W; Renner, W; Discrepancy between history and biochemically specific Smoking status in Patients of LURIC Study.
INTERNIST. 2013; 54: 106-106.-Jahrestagung der ÖKG; Juni 5-8, 2013; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Drechsler, C; Ritz, E; Tomaschitz, A; Pilz, S; Schonfeld, S; Blouin, K; Bidlingmaier, M; Hammer, F; Krane, V; Marz, W; Allolio, B; Fassnacht, M; Wanner, C; ALDOSTERONE AND CORTISOL AFFECT THE RISK OF SUDDEN CARDIAC DEATH IN HAEMODIALYSIS PATIENTS.
NEPHROL DIALYSIS TRANSPLANT. 2012; 27: 59-59.-49th Congress of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA); MAY 24-27, 2012; Paris, FRANCE. [Poster]
Web of Science

 

Kleber, ME; Siekmeier, R; Grammer, TB; Winkelmann, BR; Boehm, BO; Marz, W Importance of the von Willebrand factor, factor VIII, PAI-1 and t-PA Study as Predictors of mortality in Ludwigshafen Risk and Cardiovascular Health Study
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):577-577. [Poster]
Web of Science

 

Lam, U; Lerchbaum, E; Schweighofer, N; Trummer, O; Eberhard, K; Groselj-Strele, A; Genser, B; Boehm, B; Winkelmann, B; März, W; Pieber, T; Obermayer-Pietsch, B Relation of a Genetic Variant of MEP1A with Insulin Metabolism in Women with Polycystic Ovary Syndrome.
The Second International Genomics Conference “Genomics for Healthcare and Socio-Economic Progress”. 2012; SEPT 13-14, 2012; Cardiff, UNITED KINGDOM. [Poster]

 

Lerchbaum, E; Pilz, S; Boehm, BO; Grammer, TB, März, W; Obermayer-Pietsch, B COMBINATION OF LOW FREE TESTOSTERONE AND LOW VITAMIN D PREDICTS MORTALITY IN OLDER MEN REFERRED FOR CORONARY ANGIOGRAPHY
Journal für Klinische Endokrinologie und Stoffwechsel. 2012; -17. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel; APR 19-20, 2012; Graz, AUSTRIA. [Oral Communication]

 

Lerchbaum,E; Pilz,S; Boehm,BO; Grammer,TB; März W; Obermayer-Pietsch B COMBINATION OF LOW FREE TESTOSTERONE AND LOW VITAMIN D PREDICTS MORTALITY IN OLDER MEN REFERRED FOR CORONARY ANGIOGRAPHY
Maturitas. 2012; -9th European Congress on Menopause and Andropause; MAR 28-31, 2012; Athens, GREECE. [Oral Communication]

 

Maerz, W; Genser, B; Benz, J; Drechlser, C; Krane, V; Grammer, TB; Ritz, E; Scharnagl, H; Wanner, C Lipoprotein-associated phospholipase A2 (LpPLA2), cardiovascular events and mortality in patients with type 2 diabetes mellitus on hemodialysis.
EUR HEART J. 2012; 33: 1077-1077.-Congress of the European-Society-of-Cardiology (ESC); AUG 25-29, 2012; Munchen, GERMANY. [Poster]
Web of Science

 

Putz-Bankuti, C; Pilz, S; Meinitzer, A; Maerz, W; Kienreich, K; Stojakovic, T; Trauner, M; Pieber, TR; Stauber, RE ASSOCIATION OF HOMOARGININE AND METHYLARGININES WITH LIVER DYSFUNCTION AND MORTALITY IN CIRRHOTIC PATIENTS.
J HEPATOL. 2012; 56(S2):S255-S255.-47th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(12)60656-4 [Poster]
Web of Science FullText FullText_MUG

 

Putz-Bankuti, C; Pilz, S; Meinitzer, A; März, W; Kienreich, K; Stojakovic, T; Trauner, M; Pieber, TR; Stauber, RE Association of homoarginine and methylarginines with liver dysfunction and mortality in cirrhotic patients.
Z Gastroenterol. 2012; 50(5):517-517.-45. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 14-16, 2012; Wels, AUSTRIA. [Poster]

 

Tomaschitz A; Meinitzer, A; Pieske, P; Kienreich, K; März, W; Ritz, E; Fahrleitner-Pammer, A; Grammer, T; Kraigher-Krainer, E; Colantonio, C; Toplak, H; Drechsle, C; Verheyen, N; Pilz, S Associations of Tryptophan Metabolism with Metabolic Traits in Hypertensive Patients: the Graz Endocrine Causes of Hypertension (GECOH) Study
Abstraktband. 2012; -Biomarkers in Heart Failuren with Preserved Ejection Fraction - International Symposium; OCT 13-15, 2012; Graz, AUSTRIA. [Poster]

 

Tomaschitz, A; Edelmann, F; Pilz, S; Meinitzer, A; Schmidt, A; Ritz, E; Gelbrich, G; Düngen, HD; Kienreich, K; Stahrenberg, R; Wachter, R; März, W; Pieske, B Associations of Methylarginines and Homoarginine with Diastolic Dysfunction in Patients at Cardiovascular Risk with Preserved Left Ventricular Ejection Fraction
Journal of Cardiology 2012; 19 (5-6), 123-194. 2012; 158-159.-Jahrestagung der Österreichischen Kardiologischen Gesellschaft; May 30 - JUNE 2, 2012; Salzburg, Austria. [Poster]

 

Tomaschitz, A; Edelmann, F; Pilz, S; Meinitzer, A; Schmidt, A; Ritz, E; Gelbrich, G; Düngen, HD; Kienreich, K; Stahrenberg, R; Wachter, R; März, W; Pieske, B Associations of Methylarginines and Homoarginine with Diastolic Dysfunction in Patients at Cardiovascular Risk with Preserved Left Ventricular Ejection Fraction
Abstraktband. 2012; -Biomarkers in Heart Failuren with Preserved Ejection Fraction - International Symposium; OCT 13-15, 2012; Graz, AUSTRIA. [Poster]

 

Tomaschitz, A; Kienreich, K; Pilz, S; Ritz, E; Grammer, T; Pieske, B; Boehm, BO; März, W Plasma Renin and Cardiovascular Mortality in Patients with Type 2 Diabetes: A 10-Year Cohort Study
Journal of Cardiology 2012; 19 (5-6), 123-194. 2012;. 2012; 188--Jahrestagung der Österreichischen Kardiologischen Gesellschaft ; May 30 - JUNE 2, 2012; Salzburg, Austria. [Poster]

 

Tomaschitz, A; Meinitzer, M; Pilz, S; Kienreich, K; Genser, B; Drechsler, C; Grammer, T; Krane, V; Ritz, E; Kleber, ME; Pieske, B; Fahrleitner-Pammer, A; Wanner, C; Boehm, BO; März, W Homoarginine, Kidney Function and Related 10-year Cardiovascular Mortality Risk
Abstraktband. 2012; -Biomarkers in Heart Failuren with Preserved Ejection Fraction - International Symposium; OCT 13-15, 2012; Graz, AUSTRIA. [Poster]

 

Tomaschitz A; Piecha, G; Ritz, E; Meinitzer, A; Pieske, P; Fahrleitner-Pammer, A; März, W; Kienreich, K; Grammer, T; Verheyen, N; Pilz, S Marinobufagenin in arterial hypertension: a promising biomarker for cardiovascular and renal diseases? Cross-sectional relations from the Graz Endocrine Causes of Hypertension (GECOH) Study
Abstract-Band . 2012; -Biomarkers in Heart Failuren with Preserved Ejection Fraction - International Symposium; OCT 13-15, 2012; Graz, AUSTRIA. [Poster]

 

Tomaschitz, A; Pilz, S; Pieske, B; Ritz, E; März, W; Meinitzer, A; Dobnig, H; Amrein, K; Kienreich, K; Kraigher-Krainer, E; Colantonio, C; Wagner, D; Fahrleitner-Pammer, A Circulating Aldosterone and Mortality in Female Nursing Home Residents
Abstraktband. 2012; -Biomarkers in Heart Failuren with Preserved Ejection Fraction - International Symposium; OCT 13-15, 2012; Graz, AUSTRIA. [Poster]

 

Tomaschitz, A; Pilz, S; Ritz, E; Pieske, B; Grammer, T; Meinitzer, A; Boehm, BO; März, W Plasma Renin and Cardiovascular Mortality in Patients with Diabetes: a 10-year Cohort Study
Page 330, P5719. 2012; -ESC Congress 2012; AUG 25-29, 2012; Munich, Germany. [Poster]

 

Tomaschitz, A; Pilz, S; Ritz, E; Pieske, B; Grammer, T; Meinitzer, A; Kienreich, K; Boehm, BO; Maerz, W; Plasma renin strongly predicts all-cause and cardiovascular mortality in patients with type 2 diabetes: a 10-year cohort study.
EUR HEART J. 2012; 33: 1074-1074.-Congress of the European-Society-of-Cardiology (ESC); AUG 25-29, 2012; Munchen, GERMANY. [Poster]
Web of Science

 

Trummer, O; Pilz, S; Hoffmann, M; Winkelmann, B; Boehm, B; Marz, W; Pieber, TR; Renner, W; Obermayer-Pietsch, B; Vitamin D levels, vitamin D insufficiency genotypes and mortality: A Mendelian randomization study.
BONE. 2012; 50: S108-S109.-39th Annual Congress of the European-Calcified-Tissue-Society (ECTS); MAY 19-23, 2012; Stockholm, SWEDEN. Doi: 10.1016/j.bone.2012.02.331 [Poster]
Web of Science FullText FullText_MUG

 

Trummer, O; Pilz, S; Hoffmann, MM; Winkelmann, BR; Boehm, BO; Marz, W; Pieber, TR; Renner, W; Obermayer-Pietsch, B Vitamin D levels, Vitamin D Insufficiency Genotypes and Mortality
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):564-564. [Poster]
Web of Science

 

Wallner-Liebmann, SJ; Grammer, TB; Mangge, H; März, W; Renner, W Smoking denial in cardiovascular disease studies.
Drug Metabolism and Drug Interactions. 2012; 27(3):44-44.-6th Santorini Conference Biologie Prospective; SEP 30-OKT 2, 2012; Thira, GREECE. [Poster]

 

Genser, B; Silbernagel, G; De Backer, G; Bruckert, E; Carmena, R; Chapman, J; Deanfield, J; Descamps, OS; Rietzschel, ER; Marz, W Plant sterols and cardiovascular disease: a meta-analysis of 17 studies
EUR HEART J. 2011; 32: 720-720.
Web of Science

 

Genser, B; Silbernagel, G; De Backer, G; Bruckert, E; Carmena, R; Chapman, J; Deanfield, J; Descamps, OS; Rietzschel, ER; Marz, W Plant sterols and cardiovascular disease: a meta-analysis of 17 studies
AM J RESP CRIT CARE. 2011; 183: 720-720.
Web of Science

 

Grammer, T; Silbernagel, G; Pilz, S; Kleber, M; Tomaschitz, A; Boehm, B; Winkelmann, B; Maerz, W ANEMIA AND IRON DEPLETION INDEPENDENTLY ASSOCIATED WITH ANGIOGRAPHIC CORONARY ARTERY DISEASE. (THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH STUDY)
ATHEROSCLEROSIS SUPP. 2011; 12(1): 108-108. Doi: 10.1016/S1567-5688(11)70510-4
Web of Science FullText FullText_MUG

 

Haucinger, N; Tomaschitz, A; Pilz, S; Ritz, E; Grammer, T; Amrein, K; Meinitzer, A; Boehm, BO; März, W RELATIONSHIP OF THYROID HORMONES WITH THE CIRCULATING RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
Journal of Clinical Endocrinology and Metabolism 2011; 4 (Sonderheft 1), 5-232011; 19-19.-16. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel; MAI 12-13, 2011; Vienna, AUSTRIA. [Poster]
FullText

 

Isermann, BH; Schneider, J; Kleber, ME; Wang, HJ; Boehm, BO; Grammer, TB; Pruller, F; Nawroth, PP; Marz, W Intermediate Thrombin Activation Is Associated with Reduced Cardiovascular Death Independently of Markers of Lipid Metabolism and Inflammation
BLOOD. 2011; 118(21):18-18.-53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis; DEC 10-13, 2011; San Diego, CA. [Oral Communication]
Web of Science

 

Lam, U; Wehr, E; Schweighofer, N; Trummer, O; Genser, B; Boehm, B; Winkelmann, B; März, W; Pieber, T; Obermayer-Pietsch, B Genome-wide association study of the PolyCystic Ovary Syndrome: distribution of promising gene variants associated with testosterone in the LURIC cohort.
European Society of Human Genetics. 2011; 19(Supl 2):259-259.MAY 28–31, 2011; Amsterdam, the Netherlands . [Poster]

 

Lam, U; Wehr, E; Schweighofer, N; Trummer, O; Genser, B; Boehm, B; Winkelmann, B; März, W; Pieber, T; Obermayer-Pietsch, B Polycystic Ovary Syndrome in a Genome-wide Association Study.
The 16 Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel. 2011; MAY 12–13, 2011; Vienna, AUSTRIA . [Poster]

 

Lam, U; Wehr, E; Schweighofer, N; Trummer, O; Genser, B; Boehm, B; Winkelmann, B; März, W; Pieber, T; Obermayer-Pietsch, B Genome-wide Association Study: new genetic variation associated with different phenotype and especially special elevated testosterone in polycystic ovary syndrome.
Doctoral Day. 2011; NOV 4, 2011 ; Graz, AUSTRIA. [Poster]

 

Lam, U; Wehr, E; Schweighofer, N; Trummer, O; Genser, B; Boehm, BO; Winkelmann, BR; März, W; Pieber, T; Obermayer-Pietsch, B Genome-wide Association Study of the Polycystic Ovary Syndrome: Distribution of Promising Gene Variants Associated with Testosterone in the LURIC Cohort.
Proceeding of the 16. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel. 2011; -Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel; Mai 12–13, 2011; Vienna, AUSTRIA . [Poster]

 

Marz, W; Silbernagel, G; De Backer, G; Bruckert, E; Carmena, R; Chapman, J; Deanfield, J; Descamps, OS; Rietzschel, ER; Dias, KC; Genser, B PLANT STEROLS AND CARDIOVASCULAR DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
ATHEROSCLEROSIS SUPP. 2011; 12(1): 8-8.
Web of Science

 

Murr, C; Pilz, S; Grammer, TB; Kleber, M; Böhm, BO; März, W; Fuchs, D Inflammation and Immune Activation May Underlie Vitamin D Deficiency. The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
Pteridines. 2011; 22(2):48-49.-30th International Winter-Workshop on Clinical, Chemical, and Biochemical Aspects of Pteridines; MAR, 13-20, 2011; St. Christophus, Arlberg, AUSTRIA. [Oral Communication]

 

Murr, C; Pilz, S; Grammer, TB; Kleber, M; Böhm, BO; März, W; Fuchs, D Zinc and Neopterin in Patients with and without Angiographic Coronary Artery Disease: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
Pteridines. 2011; 22(2):46-47.-30th International Winter-Workshop on Clinical, Chemical, and Biochemical Aspects of Pteridines; MAR, 13-20, 2011; St. Christophus, Arlberg, AUSTRIA. [Oral Communication]

 

Pilz, S; Meinitzer, A; Tomaschitz, A; Drechsler, C; Ritz, E; Krane, V; Wanner, C; Böhm, BO; März, W Low homoarginine levels are a novel risk factor for heart diseases
J Klin Endokrinol Stoffw 20112011; 4 (Sonderheft 1): 16--16. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel; MAY 12-13, 2011; Vienna, AUSTRIA. [Poster]

 

Pilz, S; Tomaschitz, A; Friedl, C; Amrein, K; Drechsler, C; Ritz E; Böhm, BO; Grammer, TB; März, W Vitamin D status and mortality in chronic kidney disease
J Klin Endokrinol Stoffw2011; 4 (Sonderheft 1): 15--16. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel; MAY 12-13, 2011; Vienna, AUSTRIA. [Oral Communication]

 

Silbernagel, G; Kleber, ME; Grammer, TB; Winkelmann, BR; Boehm, BO; Marz, W GLYCATED HEMOGLOBIN FOR THE DIAGNOSIS OF TYPE 2 DIABETES IN PERSONS UNDERGOING CORONARY ANGIOGRAPHY: THE LURIC STUDY
ATHEROSCLEROSIS SUPP. 2011; 12(1): 62-63. Doi: 10.1016/S1567-5688(11)70289-6
Web of Science FullText FullText_MUG

 

Silbernagel, G; Rosinger, S; Grammer, TB; Winkelmann, BR; Boehm, BO; Marz, W DURATION OF TYPE 2 DIABETES STRONGLY PREDICTS ALL-CAUSE MORTALITY, CARDIOVASCULAR MORTALITY AND DEATH FROM STROKE IN SUBJECTS UNDERGOING CORONARY ANGIOGRAPHY
ATHEROSCLEROSIS SUPP. 2011; 12(1): 6-6. Doi: 10.1016/S1567-5688(11)70029-0
Web of Science FullText FullText_MUG

 

Silbernagel, G; Sourij, H; Kleber, ME; Grammer, TB; Winkelmann, BR; Boehm, BO; Marz, W Post-challenge glucose levels identify a high risk group for all-cause and cardiovascular mortality undetected by fasting glucose or glycated hemoglobin
EUR HEART J. 2011; 32: 974-974.
Web of Science

 

Tomaschitz, A; Pilz, S; Ritz, E; Amrein, K; Grammer, T; Genser, B; Kleber, M; Drechsler, C; Hoffmann, MM; Boehm, BO; März, W Variants of the Crpytochrome-2 clock gene are related to higher circulating aldosterone levels and cardiovascular mortality
16. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel ; MAI 12-13, 2011; Vienna, AUSTRIA. 2011. [Oral Communication]

 

Tomaschitz, A; Pilz, S; Ritz, E; Amrein, K; Grammer, T; Genser, B; Kleber, M; Drechsler, C; Hoffmann, MM; Boehm, BO; März, W Variants of the Cryptochrome-2 Clock Gene Are Related to Higher Circulating Aldosterone Levels and Cardiovascular Mortality. The Ludwigshafen Risk and Cardiovascular (LURIC) Study
Journal of Clinical Endocrinology and Metabolism 2011; 4 (Sonderheft 1), 5-232011; 19-20.-16. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel ; MAI 12-13, 2011; Vienna, AUSTRIA. [Oral Communication]
FullText

 

Tomaschitz, A; Pilz, S; Ritz, E; Grammer, T; Kienreich, K; Winkelmann, BR; Boehm, BO; März, W Serum Cortisol and Cardiovascular Mortality in Men with Chronic Kidney Disease
Journal of men´s health doi: 10.1016/j.jomh.2011.08.098. 2011; 8(3):240-240.-8th Men´s health congress & 4th european men´s health conference; OCT 2-5, 2011; Vienna, AUSTRIA. Doi: 10.1016/j.jomh.2011.08.098 [Oral Communication]
Web of Science FullText FullText_MUG

 

Tomaschitz, A; Pilz, S; Ritz, E; Kleber, M; Genser, B; Grammer, T; Hoffmann, MM; Boehm, BO; Winkelmann, BR; März, W GENOME-WIDE ASSOCIATION STUDY IDENTIFIES GENETIC VARIATIONS INFLUENCING ARR LEVELS IN CAUCASIAN: THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH (LURIC) STUDY
From basic research to clinical evidence2011; -Progress in Primary Aldosteronism 2; MAY 4-6, 2011; Munich, GERMANY. [Oral Communication]
FullText

 

Tomaschitz, A; Pilz, S; Ritz, E; Kleber, M; Grammer, T; Meinitzer, A; Boehm, BO; März, W Relationship between plasma aldosterone concentration and soluble cellular adhesion molecules in patients referred to coronary angiography
Journal of Clinical Endocrinology and Metabolism 2011; 4 (Sonderheft 1), 5-232011; 19-19.-16. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel; MAI 12-13, 2011; Vienna, AUSTRIA. [Poster]
FullText

 

Tomaschitz, A; Pilz, S; Ritz, E; Morganti, A; Grammer, T; Amrein, K; Boehm, BO; März, W ASSOCIATIONS OF PLASMA RENIN WITH 10-YEAR CARDIOVASCULAR MORTALITY, SUDDEN CARDIAC DEATH AND DEATH DUE TO HEART FAILURE
Journal of Hypertension, e-Supplement A, June 2011. 2011; 29: 56--21st European Meeting on Hypertension and Cardiovascular Prevention; JUNE 17-20, 2011; Milan, ITALY. [Oral Communication]

 

Tripolt, NJ; Sourij, H; Böhm, BO; März, W Low 25(OH)-Vitamin D levels are associted with increased mortality in patients with postchallenge hyperglycemia and diabetes mellitus referred to coronary angiography
Journal of Diabetes, Abstract book2011; 3 Supplement 1: -4th International Congress of Prediabetes and Metabolic Syndrome; APR 6-9, 2011; Madrid, SPAIN. [Poster]

 

Dobnig, H; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Kinkeldei, J; Bohm, B; Fahrleitner-Pammer, A; Marz, W INFLUENCE OF 25-HYDROXYVITAMIN D STATUS ON SERUM PARATHYROID HORMONE LEVELS VARIES WITH KDOQI CLASSIFICATION OF RENAL FUNCTION AND IS INDEPENDENT OF 1,25 DIHYDROXYVITAMIN D CONCENTRATIONS
OSTEOPOROSIS INT. 2010; 21: 11-11. -IOF World Congress on Osteoporosis 10Th European Congress on Clinical an Economic Aspects of Osteoporosis and Osteoarthritis ; 5-8 May ; Florence, Italy. [Oral Communication]
Web of Science FullText

 

Eller, P; Ritsch, A; Scharnagl, H; Tancevski, I; Duwensee, K; Demetz, E; Sandhofer, A; Boehm, B; Winkelmann, B; Patsch, J; Marz, W CHOLESTERYL ESTER TRANSFER PROTEIN AND MORTALITY IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
ATHEROSCLER SUPPL. 2010; 11(2):P259--78th Congress of the European Atherosclerosis Society; JUNE 20-23, 2010; Hamburg, GERMANY. Doi: 10.1016/S1567-5688(10)70326-3 [Poster]
Web of Science FullText FullText_MUG

 

Fauler, G; Silbernagel, G; Winkelmann, B; Boehm, B; Marz, W PLASMA PLANT STEROLS AND THE RISK OF CORONARY HEART DISEASE
ATHEROSCLER SUPPL. 2010; 11(2): MS110 Doi: 10.1016/S1567-5688(10)70611-5 [Poster]
Web of Science FullText FullText_MUG

 

Genser, B; Dias, K; Siekmeier, R; Stojakovic, T; Grammer, T; Marz, W LIPOPROTEIN(a) AND THE RISK OF CARDIOVASCULAR DISEASE - SYSTEMATIC REVIEW AND META ANALYSIS OF PROSPECTIVE STUDIES INCLUDING 161222 INDIVIDUALS
ATHEROSCLER SUPPL. 2010; 11(2): P125-78th Congress of the European Atherosclerosis Society; JUN 20-23, 2010; Hamburg, GERMANY. Doi: 10.1016/S1567-5688(10)70192-6 [Poster]
Web of Science FullText FullText_MUG

 

Genser, B; Dias, K; Siekmeier, R; Stojakovic, T; Grammer, T; Marz, W Lp(a) and cardio-vascular risk - meta-analysis from the prospective study with 161222 patients.
MED KLIN. 2010; 105(3):214-215.-116. Kongress der Deutschen Gesellschaft für Innere Medizin; APR 10-14, 2010; Wiesbaden, GERMANY. [Poster]
Web of Science

 

Genser, B; Dias, K; Siekmeier, R; Stojakovic, T; Grammer, T; Marz, W Lp(a) as a risk factor for cardiovascular disease - systematic literature review and meta-analysis of prospective studies involving 181 683 patients
WIEN KLIN WOCHENSCHR. 2010; 122(17-18):A26-A26.-41. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 29-OCT 2, 2010; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Grammer, TB; März, W; Genser, B; Drechsler, C; Krane, V; Ritz, E; Stojakovic, T; Scharnagl, H; Holme, I; Holdaas, H; Wanner, C Herz und Niere: Wirkung von Atorvastatin bei Patienten mit dialysepflichtiger Niereninsuffizienz und hohem LDL-Cholesterin.
40. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27, 2010; Maikammer, GERMANY. 2010. [Oral Communication]

 

Lam, U; Wehr, E; Schweighofer, N; Trummer, O; Genser, B; Boehm, BO; Winkelmann, BR; März, W; Pieber, T; Obermayer-Pietsch, B Polycystic Ovary Syndrome in a Genome-wide Association Study.
15. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel; MAI 7–8, 2010; Vienna, AUSTRIA. 2010. [Poster]

 

Lam, U; Wehr, E; Schweighofer, N; Trummer, O; Genser, B; Boehm, BO; Winkelmann, BR; März, W; Pieber, T; Obermayer-Pietsch, B Polycystic Ovary Syndrome in a Genome-wide Association Study.
The 15 Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel. 2010; MAI 7–8, 2010; Vienna, AUSTRIA. [Poster]

 

Lam, U; Wehr, E; Schweighofer, N; Trummer, O; Genser, B; März, W; Pieber, T; Obermayer-Pietsch, B Polycystic Ovary Syndrome – Perspective of a New Candidate Gene – Derived from Genome-wide Association Study.
Young Scientist Association - PhD Symposium ; JUNE 16-17, 2010; Vienna, AUSTRIA. 2010. [Poster]
FullText

 

Lam, U; Wehr, E; Schweighofer, N; Trummer, O; Genser, B; März, W; Pieber, T; Obermayer-Pietsch, B Polycystic Ovary Syndrome – Perspective of a New Candidate Gene – Derived from Genome-wide Association Study
Young Scientist Association-PhD Symposium . 2010; JUNE 16-17, 2010; Vienna, AUSTRIA. [Poster]

 

Maerz, W; Meinitzer, A; Drechsler, C; Pilz, S; Krane, V; Kleber, M; Fischer, J; Winkelmann, B; Boehm, B; Ritz, E; Wanner, C Homoarginine, cardiovascular risk and mortality
Clinical Chemistry and Laboratory Medicine. 2010; 49(9):A92-A92.-7th Annual Conference of the German Society for Clinical Chemistry and Laboratory Medicine; Sep 29-Oct 02; Mannheim, Germany. [Oral Communication]

 

Maerz, W; Meinitzer, A; Drechsler, C; Pilz, S; Krane, V; Kleber, M; Fischer, J; Ritz, E; Wanner, C Homoarginine, cardiovascular risk and mortality
EUR HEART J. 2010; 31: 811-811.
Web of Science

 

Marz, W; Meinitzer, A; Pilz, S; Drechsler, C; Krane, V; Kleber, M; Fischer, J; Winkelmann, B; Bohm, B; Ritz, E; Wanner, C HOMOARGININE INDEPENDENTLY PREDICTS TOTAL AND CARDIOVASCULAR MORTALITY IN INDIVIDUALS WITH ANGIOGRAPHIC CORONARY ARTERY DISEASE
ATHEROSCLER SUPPL. 2010; 11(2):MS535--European Society of Cardiology (ESC) Congress 2010, ; 28. August - 01. September 2010; Stockholm, Sweden . [Poster]
Web of Science

 

Pilz, S; Tomaschitz, A; Drechsler, C; Winkelmann, BR; Boehm, BO; Grammer, T; Marz, W Parathyroid hormone is associated with mortality and cardiovascular events in patients undergoing coronary angiography
EUR J CLIN INVEST. 2010; 40: 64-65. [Poster]
Web of Science

 

Scharnagl, H; Stojakovic, T; Weihrauch, G; Winkelmann, BR; Boehm, BO; Maerz, W INTERLEUKIN-6 IS STRONGER ASSOCIATED WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITY THAN C-REACTIVE PROTEIN, SERUM AMYLOID A AND FIBRINOGEN (THE LURIC STUDY)
ATHEROSCLER SUPPL. 2010; 11(2):P124--78th Congress of the European Atherosclerosis Society; JUNE 20-23, 2010; Hamburg, GERMANY. Doi: 10.1016/S1567-5688(10)70191-4 [Poster]
Web of Science FullText FullText_MUG

 

Scharnagl, H; Weihrauch, G; Dobnig, H; Stojakovic, T; Meinitzer, A; Winkelmann, BR; Boehm, BO; März, W The association of cystatin C, serum creatinine and creatinine clearance with cardiovascular mortality in the LURIC study.
40. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27, 2010; Maikammer, GERMANY. 2010. [Oral Communication]

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; Marz, W; Wascher, TC; Trauner, M LOW-DOSE ATORVASTATIN IMPROVES DYSLIPIDEMIA AND VASCULAR FUNCTION IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS AFTER ONE YEAR OF TREATMENT.
J HEPATOL. 2010; 52: S431-S432.-45th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 14-18, 2010; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(10)61118-X [Poster]
Web of Science FullText FullText_MUG

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
3rd Annual Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry; OCT 27-30, 2010; Salzburg, AUSTRIA. 2010. [Oral Communication]

 

Tomaschitz, A; Pilz, S; Ritz, E; Boehm, BO; Maerz, W DOES AN INDEPENDENT ASSOCIATION BETWEEN VITAMIN D AND PLASMA RENIN CONCENTRATION MODULATE CARDIOVASCULAR MORTALITY?
J HYPERTENSION. 2010; 28: E226-E226. Doi: 10.1097/01.hjh.0000378885.21600.fb [Oral Communication]
Web of Science FullText FullText_MUG

 

Tomaschitz, A; Pilz, S; Ritz, E; Grammer, T; Drechsler, C; Boehm, BO; März, W Serum Cortisol Predicts Increased Cardiovascular Mortality in Patients with Acute Coronary Syndrome The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
Endocrine Abstracts April 2010 Volume 22, ISSN 1470-39472010; -12th European Congress of Endocrinology; April 24-28, 2010; Prague, Czech Republic. [Oral Communication]

 

Tomaschitz, A; Pilz, S; Ritz, E; Grammer, T; Drechsler, C; Boehm, BO; März, W; Serum Cortisol Predicts Increased Cardiovascular Mortality in Patients with Acute Coronary Syndrome
Abstractband ÖGES 20102010; -15. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel; MAY 7-8, 2010; Vienna, AUSTRIA. [Oral Communication]

 

Tomaschitz, A; Pilz, S; Ritz, E; Grammer, T; Drechsler, C; Winkelmann, BR; Boehm, BO & März, W Aldosterone predicts cardiovascular mortality in patients with mildly impaired renal function:The Ludwigshafen Risk and Cardiovascular Health LURIC Study.
Special Issue: Volume 40 Issue s1 , Pages 1 - 101 (March 2010)2010; -44th Annual Scientific Meeting of the European Society for Clinical Investigation; FEB 24-27, 2010; Bari, ITALY. [Poster]

 

Tomaschitz, A; Pilz, S; Ritz, E; Grammer, T; Drechsler, C; Winkelmann, BR; Boehm, BO; Marz, W Aldosterone predicts cardiovascular mortality in patients with mildly impaired renal function: The Ludwigshafen Risk and Cardiovascular Health LURIC Study
EUR J CLIN INVEST. 2010; 40: 5-6. [Poster]
Web of Science

 

Tomaschitz, A; Ritz, E; Pilz, S; Grammer, T; Drechsler, C; Boehm, BO; März, W Aldosterone is Associated with Increased Cardiovascular Mortality in Patients with Mildly Impaired Renal Function
http://dir.isn-online.org/ISN/nexus/2010; -ISN Nexus Symposium 2010; April 15-18, 2010; Kyoto, JAPAN. [Poster]

 

Wehr, E; Pilz, S; Boehm, BO; März, W; Obermayer-Pietsch, B Assoziation zwischen Vitamin D und Androgenen bei Männern
Osteologie2010; -Osteologie 2010; MAR 3-6, 2010; Berlin, Germany. [Poster]

 

Wehr, E; Pilz, S; Boehm BO; März, W; Obermayer-Pietsch, B Association of vitamin D status with serum androgen levels in men
Endocrinology. 2010; -European Congress of Endocrinology; APR 24-28; Prag, Czech Republic. [Poster]

 

Dobnig, H; Pilz, S; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Fahrleitner-Pammer, A; Bohm, BO; Marz, W 25-hydroxyvitamin D levels and association with all-cause mortality in patients with type 2 diabetes mellitus
DIABETOLOGIA. 2009; 52: 316--44th General Assembly of the European Association for the Study of Diabetes (EASD); SEP 7-11, 2009; Rome, ITALY. [Poster]
Web of Science

 

Dobnig, H; Pilz, S; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Kinkeldei, J; Bohm, B; Fahrleitner-Pammer, A; Marz, W Influence of 25-hydroxyvitamin D and 1,25 dihydroxyvitamin D status on serum parathyroid hormone levels varies at different levels of renal function
BONE. 2009; 44(2):S360-S360.-36th European Symposium on Calcified Tissue; MAY 23-27, 2009; Vienna, Austria. Doi: 10.1016/j.bone.2009.03.193 [Poster]
Web of Science FullText FullText_MUG

 

Dobnig, H; Pilz, S; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Kinkeldei, J; Böhm, B; Fahrleitner-Pammer, A; März, W Influence of 25-hydroxyvitamin D status on serum PTH levels varies with KDOQI classification of renal function and is independent of 1,25 dihydroxyvitamin D concentration
Journal of Bone and Mineral Society, Suppl.2009; -American Society for Bone and Mineral Research; SEP 11-15, 2009; Denver, USA. [Oral Communication]

 

Pilz, S; Tomaschitz, A; Boehm, BO; Maerz, W Freie Fettsäuren sind mit einer reduzierten linksventrikulären Funktion assoziiert
WKW. 2009; -10. Jahrestagung der Österreichischen Adipositas Gesellschaft; 30-31. Oct.; Seggau, Ö. [Poster]

 

Pilz, S; Tomaschitz, A; Boehm, BO; Maerz, W Assoziationen von 25-Hydroxyvitamin D mit Lipoproteinen
wkw. 2009; -10. Jahrestagung der Österreichischen Adipositas Gesellschaft; 30-31. Oct.; Seggau, Ö. [Poster]

 

Pilz, S; Tomaschitz, A; Boehm, BO; Wimkelmann, BR; Marz, W Vitamin D deficiency is associated with type 2 diabetes mellitus and insulin resistance in 3290 patients referred to coronary angiography
DIABETOLOGIA. 2009; 52: 309--45th EASD Annual Meeting; Sept 29 - Oct 2, 2009; Vienna, Austria. [Poster]
Web of Science

 

Scharnagl, H; Stojakovic, T; Winkler, K; Seelhorst, U; Wellnitz, B; Böhm, BO; März, W; Hoffmann, MM Apolipoprotein C-III: a predictor of cardiovascular mortality? (The Ludwigshafen Risk and Cardiovascular Health Study).
16. Jahrestagung der Österreichischen Atherosklerosegesellschaft – Austrian Atherosclerosis Society (AAS). ; MAI 8-9, 2009; St.Gilgen/Wolfgangsee, AUSTRIA. 2009. [Oral Communication]

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
39. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 26-28, 2009; Maikammer, GERMANY. 2009. [Oral Communication]

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M Improvement of lipoprotein pattern and vascular function in patients with primary biliary cirrhosis after long-term treatment with atorvastatin.
1st Styrian Conference on Lipid Mass Spectrometry; OCT 21-22, 2009; Graz, AUSTRIA. 2009. [Poster]

 

Stojakovic, T; de Campo, A; Scharnagl, H; Sourij, H; Schmölzer, I; Wascher, TC; März W Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients with type 2 diabetes and/or coronary heart disease.
Clin Chem Lab Med 2009; 47(9):A47-A47.-6th Annual Conference of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL); OCT 7-10, 2009; Leipzig, GERMANY. [Poster]

 

Stojakovic, T; de Campo, A; Scharnagl, H; Sourij, I; Schmolzer, I; Wascher, TC; Marz, W Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A20-A20.-40. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, M; Wagner, M; Sourij, H; Stauber, RE; Marz, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A26-A26.-40.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

Tomaschitz, A; Maerz, W; Pilz, S; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Boehm, BO; Fahrleitner-Pammer, A; Wiehrauch, G; Dobnig, H Aldosterone-to-Renin Ratio Determines Peripheral and Central Blood Pressure Values Over a Broad Range and Well Below a Cut-off Suggestive of Primary Aldosteronism.
14. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel; Mai 7-9, 2009 ; St.Wolfgang-Salzkammergut, Austria. 2009. [Oral Communication]

 

Tomaschitz, A; Marz, W; Pilz, S; Winkelmann, BR; Boehm, BO; Dobnig, H ASSOCIATION BETWEEN INCREASED SYMPATHETIC ACTIVITY AND ADRENAL ALDOSTERONE SECRETION
J HYPERTENSION. 2009; 27: S444-S444.-19th official scientific meeting of the European Society of Hypertension; Jun 12-16, 2009; Milano, ITALY. [Poster]
Web of Science

 

Tomaschitz, A; März, W; Pilz, S; Winkelmann, BR; Boehm, BO; Dobnig, H Association between increased symathetic acitivty and adrenal aldosterone secretion
Abstract Book of the 19th European Meeting on Hypertension2009; -19th European Meeting on Hypertension; June 12-16, 2009; Milan, ITALY. [Poster]

 

Tomaschitz, A; Pilz, S; Boehm, BO; März, W Assoziation zwischen Aldosteron und Plasmalipiden The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
10. Jahrestagung der Österreichischen Adipositas Gesellschaft; 30. Oct-31.Oct.; Seggau, Ö. 2009. [Oral Communication]

 

Tomaschitz, A; Pilz, S; Boehm, BO; März, W Ist Aldosteron an der Regulation von Leptin entscheidend beteiligt?
10. Jahrestagung der Österreichischen Adipositas Gesellschaft; 30. Oct-31.Oct.; Seggau, Ö. 2009. [Oral Communication]

 

Tomaschitz, A; Pilz, S; Dobnig, H; Winkelmann, B; Bohm, B; Maerz, W The impact of the aldosterone to renin ratio on aortic pulse pressure in diabetic and non-diabetic patients referred to coronary angiography: LURIC Study non-profit LLC, Freiburg, Germany
EUR J CLIN INVEST. 2009; 39: 41-41.-43rd Annual Scientific Meeting of the European Society for Clinical Investigation; APR 1-4, 2009; Frankfurt/Main; GERMANY. [Poster]
Web of Science

 

Tomaschitz, A; Pilz, S; Dobnig, H; Winkelmann, BR; Renner, W; Boehm, BO; März, W Prediction of fatal stroke by high plasma aldosterone levels
Endocrine Abstracts April 2009 2009; 20: -11th European Congress of Endocrinology; APR 25-29, 2009; Istanbul, Turkey. (ISBN: 1470-3947 ) [Poster]

 

Tomaschitz, A; Pilz, S; Winkelmann, BR; Boehm, BO & Maerz, W Plasma aldosterone levels predict increased cardiovascular mortality.
Konferenzband ESC Congress 2009 P5282009; -European Society of Cardiology (ESC) Congress; 29. Aug- 2. Sept. ; Barcelona, Spain. [Poster]

 

Tomaschitz, A; Pilz, S; Winkelmann, BR; Boehm, BO; Maerz, W Independent association between the renin angiotensin aldosterone system and insulin resistance
DIABETOLOGIA. 2009; 52: 526--45th EASD Annual Meeting; Sept 29 - Oct 2, 2009; VIENNA; Austria. [Poster]
Web of Science

 

Wehr, E; Schweighofer, N; Pilz, S; März, W; Boehm, BO; Winkelmann, BR; Obermayer-Pietsch, B Assoziation von Hyperandrogenämie mit einem erhöhten Risiko für Typ 2 Diabetes und metabolischen Störungen in einer großen Kohorte postmenopausaler Frauen
Konferenzband 37. Jahrestagung der ÖDG2009; -37. Jahrestagung der ÖDG; NOV 19-21, 2009; Salzburg, AUSTRIA. [Oral Communication]

 

Wehr, E; Schweighofer, N; Pilz, S; Marz, W; Bohm, BO; Winkelmann, BR; Obermayer-Pietsch, B Association of hyperandrogenism with an increased risk for type 2 diabetes and metabolic disorders in one large cohort of postmenopausal women.
WIEN KLIN WOCHENSCHR. 2009; 121: S29-S30.
Web of Science

 

Weihrauch, G; Scharnagl, H; Seelhorst, U; Wellnitz, B; Winkelmann, BR; Boehm, BO; März, W IL 6 is independently associated with all-cause and cardiovascular mortality.
16. Jahrestagung der Österreichischen Atherosklerosegesellschaft – Austrian Atherosclerosis Society (AAS). ; MAI 8-9, 2009; St.Gilgen/Wolfgangsee, AUSTRIA. 2009. [Poster]

 

Assadian, A; Knöbl, P; Stojakovic, T; Hübl, W; Hagmüller, GW; Scharnagl, H; Winkelmann, BR; Boehm, BO; März, W Is lipoprotein(a) a useful parameter for selecting patients with asymptomatic carotid stenosis who are at risk of having a stroke?
35th Annual VEITH Symposium; NOV 19-23, 2008; New York, USA. 2008. [Oral Communication]

 

Grünbacher, G; Gutjahr, M; Boehm, BO; Winkelmann, BR; März, W; Renner W Polymorphisms and mutations of the gene encoding coagulation factor XIII alpha subunit and cardiovascular disease – results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
3. Deutscher Atherosklerosekongress; SEP 18-20, 2008; Mannheim, GERMANY. 2008. [Poster]

 

Marx-Neuhold, EA; Hoffmann, MM; März, W; Renner W ICAM-1 G214R Polymorphismus – ein Risikofaktor für koronare Herzkrankheit und Herzinfarkt?
3. Deutscher Atherosklerosekongress; SEP 18-20, 2008; Mannheim, GERMANY. 2008. [Poster]

 

März, W; Pilz, S; Mangge, H; Wellnitz, B; Seelhorst, U, Winkelmann, BR; Tiran, B; Böhm, BO Adiponektin und Mortalität bei koronarangiografierten Patienten: die LURIC-Studie.
24. Jahrestagung der Deutschen Adipositas-Gesellschaft; OCT 16-18, 2008; Freiburg, GERMANY. 2008. [Oral Communication]

 

Pilz, S; März, W; Fahrleitner-Pammer, A; Dimai, HP; Boehm, BO; Dobnig, H Vitamin D deficiency is associated with heart failure and sudden cardiac death: cross-sectional and mortality data of 3299 patients referred to coronary angiography
Endocrine Abstracts2008; (16):P228--European Congress of Endocrinology; MAY 3-7, 2008; Berlin, GERMANY. [Poster]

 

Pilz, S; März, W; Welllnitz, B; Seelhort, U; Fahrleitner-Pammer, A; Dimai, HP; Boehm, BO; Dobnig, H Vitamin D deficiency is associated with heart failure and sudden cardiac death: cross-sectional and mortality data of 3299 patients referred to coronary angiography
Journal für Klinische Endokrinologie und Stoffwechsel2008; 1(1):7-7.-Gemeinsame Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechel und der Österreichichen Gesellschaft zur Erforchung des Knochens und Mineralstoffwechsels; May 15-17, 2008; St. Wolfgang, Austria. [Oral Communication]

 

Pilz, S; März, W; Wellnitz, B; Seelhorst, U; Fahrleitner-Pammer, A; Dimai, HP; Boehm, BO; Dobnig, H Vitamin D deficiency is associated with heart failure and sudden cardiac death: cross-sectional and mortality data of 3299 patient referred to coronary angiography
Abstracts der Jahrestagung in St. Wolfgang2008; 1(1):11-11.-Gemeinsame Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel und der Österreichischen Gesellschaft zur Erforschung des Knochens und Mineralstoffwechsels; MAY 15-17, 2008; St. Wolfgang, Austria. [Oral Communication]

 

Prüller, F; Ramschak, H; Renner, W; Truschnig, M; März, W; Improved APCR assay reduces the need for further Factor V Leiden PCR testing.
Hämostaseologie - Kongressausgabe 52. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung e.V.2008; 28(1-2):A68--52. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung e.V.; FEB 20-23, 2008; Wiesbaden, GERMANY. [Poster]

 

Renner, W; Grünbacher, G; Marx-Neuhold, EA; März, W Genome-wide associations. Gaining Power by investigation of continuous phenotypes.
3. Deutscher Atherosklerosekongress; SEP 18-20, 2008; Mannheim, GERMANY. 2008. [Poster]

 

Scharnagl, H; Stojakovic, T; De Campo, A; Wascher, T; März, W The effect of fluvastatin and ezetimib on dense low density lipoproteins in patients with hypercholesterolemia and CHD.
15. Jahrestagung der Austrian Atherosclerosis Society (AAS). ; APR 18-19, 2008; St.Gilgen, AUSTRIA. 2008. [Poster]

 

Scharnagl, H; Stojakovic, T; Pittrow, D; Pieber, L; Boehler, S; Ruf, G; Maerz, W; H. Wittchen, H Association of N-terminal pro-B-type natriuretic peptide with cardiovascular risk factors: results from the DETECT study
ATHEROSCLER SUPPL 2008; 9(1):119-119.-77th Congress of the European Atherosclerosis Society; APR 26-29, 2008; Istanbul, TURKEY. [Poster]

 

Scharnagl, H; Stojakovic, T; Seelhorst, U; Wellnitz, B; Böhm, BO; März, W High concentration of LDL triglycerides predicts all-cause and cardiovascular mortality in individuals with coronary artery disease (The Ludwigshafen Risk and Cardiovascular Health Study).
3. Deutscher Atherosklerosekongress; SEP 19-20, 2008; Mannheim, DEUTSCHLAND. 2008. [Poster]

 

Stojakovic, T; de Campo, A; Scharnagl, H; Sourij, H; Schmölzer, I; Wascher, TC; März W Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events.
38. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 27-29, 2008; Maikammer, Deutschland. 2008. [Oral Communication]

 

Stojakovic, T; de Campo, A; Scharnagl, H; Sourij, H; Schmölzer, I; Wascher, TC; März W Effekte von Fluvastatin-Monotherapie oder in Kombination mit Ezetimibe auf LDL-Subfraktionen in einem Hochrisikokollektiv.
Wien Klin Wochenschr 2008; 120/19-20: S22-S22.-36. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 20-22, 2008; Baden, AUSTRIA. [Oral Communication]

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; März, W; Wascher, TC; Trauner, M Improvement of dyslipidemia and vascular function in patients with primary biliary cirrhosis after long-term treatment with atorvastatin.
Clin Chem Lab Med. 2008; 46(9):A181-A181.-5. Jahrestagung der Deutschen Vereinten Gesellschaft für Klinische Chemie und Laboratoriumsmedizin (DGKL); SEP 21-24, 2008; Mannheim, GERMANY. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Sourij, H; März, W; Wascher, TC; Trauner, M Long-term treatment with atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis.
15. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); APR 18-19, 2008; St. Gilgen, AUSTRIA. 2008. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Sourij, H; März, W; Wascher, TC; Trauner, M Long-term treatment with atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis.
Z Gastroenterol. 2008; 45: 1-1.-41. Jahrestagung und 19. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); MAI 29-31, 2008; Millstatt, AUSTRIA. [Oral Communication]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Wascher, TC; März, W; Trauner, M. Improvement of dyslipidemia and vascular function in patients with cholestatic liver disease after long-term treatment with atorvastatin
Hämostaseologie. 2008; 28(1-2):A62-A62.-52. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung e. V. (GTH); FEB 20-23, 2008; Wiesbaden, Germany. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Wagner, M; Scharnagl, H; Wascher, TC; Marz, W; Trauner, M Long-term treatment with atorvastatin in patients with cholestatic liver disease.
ATHEROSCLER SUPPL 2008; 9(1):197-197.-77th Congress of the European Atherosclerosis Society; APR 26-29, 2008; Istanbul, TURKEY. [Poster]

 

Stojakovic, T; Scharnagl, H; Trauner, M; Wellnitz, B; Seelhorst, U; Schilling, D; Winkelmann, BR; Boehm, BO; März, W Serum gamma-glutamyl transferase predicts cardiovascular mortality in persons undergoing coronary angiography – the Ludwigshafen Risk and Cardiovascular Health Study
3. Deutscher Atherosklerosekongress; SEP 19-20, 2008; Mannheim, GERMANY. 2008. [Poster]

 

Stojakovic, T; Scharnagl, H; Trauner, M; Wellnitz, B; Seelhorst, U; Winkelmann, BR; Boehm, BO; Maerz, W Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography – the Ludwigshafen Risk and Cardiovascular Health Study.
European Heart Journal 2008; 29: 592-592.-ESC Congress 2008; AUG 30 - SEP 3, 2008; Munich, GERMANY. [Poster]

 

Tomaschitz, A; Maerz, W; Pilz, S; Scharnagl, H; Renner, W; Boehm, BO; Fahrleitner-Pammer, A; Dobnig, H How does aldosterone renin ratio impact blood pressure levels? A Cross-Sectional Study of 3252 Normo- and hypertensive patients referred to coronary angiography
Endocrine Abstracts (2008) 16 P9 2008; -European Congress of Endocrinology ; 03 May 2008 - 07 May 2008; Berlin, Germany. [Poster]

 

Tomaschitz, A; März, W; Pilz, S; Scharnagl, H; Renner, W How does Aldosterone Renin Ratio Impact Blood Pressure Levels?
Journal für Klinische Endokrinologie und Stoffwechsel 2008; 1 (Sonderheft 1), 4-182008; -Gemeinsame Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel und der Österreichischen Gesellschaft zur Erforschung des Knochens und Mineralstoffwechsels; 15. bis 17. Mai 2008; St. Wolfgang, Ö. [Poster]

 

Trummer, O; Köppel, H; Grünbacher, G; Landl, E; Stanger, O; Ramschak-Schwarzer, S; Boehm, BO; Winkelmann, BR; März, W; Truschnig-Wilders, M; Renner, W The HTR2A Gene Polymorphisms are not associated with Smoking Behavior.
3. Deutscher Atherosklerosekongress; SEP 18-20, 2008; Mannheim, GERMANY. 2008. [Poster]

 

Trummer, O; Landl, EM; Fauler, G; Boehm, BO; Silbernagel, G;, März, W; Renner, W Phytosterol Transporter Gene Polymorphisms, Plant Sterols and Atherosclerosis.
3. Deutscher Atherosklerosekongress; SEP 18-20, 2008; Mannheim, GERMANY. 2008. [Poster]

 

Weihrauch, G; Dobnig, H; Scharnagl, H; Stojakovic, T; Maerz, W Association of cystatin C with mortality: data from the LURIC Study.
ATHEROSCLER SUPPL 2008; 9(1):78-79.-77th Congress of the European Atherosclerosis Society; APR 26-29, 2008; Istanbul, TURKEY. [Poster]

 

Weihrauch, G; Dobnig, H; Scharnagl, H; Stojakovic, T; Pilz, S; Seelhorst, U; Wellnitz, B; Winkelmann, BR; Boehm, BO; März, W Cystatin C and mortality in patients with cardiovascular disease - the Ludwigshafen Risk and Cardiovascular Health Study
3. Deutscher Atherosklerosekongress; SEP 19-20, 2008; Mannheim, GERMANY. 2008. [Poster]

 

Weihrauch, G; Dobnig, H; Scharnagl, H; Stojakovic, T; Pilz, S; Seelhorst, U; Wellnitz, B; Winkelmann, BR; Boehm, BO; März, W Cystatin C - A marker of mortality in patients with cardiovascular disease
15. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); APR 18-19, 2008; St. Gilgen, AUSTRIA. 2008. [Poster]

 

Zulus, B; Grünbacher, G; Stipacek, M; Truschnig-Wilders, M; Böhm, BO; März, M; Renner, W Die Rolle des UGT1A1*28 Polymorphismus für Bilirubin-Spiegel, koronare Herzkrankheit und Myokardinfarkt.
3. Deutscher Atherosklerosekongress; SEP 18-20, 2008; Mannheim, GERMANY. 2008. [Poster]

 

Abedini, S; Jardine, A; Fellstrøm, B; Weihrauch, G; März, W; Holdaas, H Symmetric dimethylarginine (SDMA) is marker for graft function and is associated with cardiac events in renal transplant recipients (RTR).
World Congress of Nephrology; APR 21-25, 2006; Rio de Janeiro. 2007. [Oral Communication]

 

Dobnig, H; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Riedmuller, G; Bruck, C; Tiran, B; Boehm, B; Maerz, W Serum concentrations of vitamin D are significant and independent predictors of mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study
EXP CLIN ENDOCRINOL DIABETES. 115: S91-S91.-51. Annual Meeting of the German Society of Endocrinology (DGE); MAR 7-10, 2007; Salzburg, Austria. [Poster]
Web of Science

 

Holdaas, H; Jardine, A; Cole, E; Marz, W; Fellstrom, B Inflammation status is associated with long-term renal and cardiac outcome in renal transplant recipients.
AM J TRANSPLANT. 2007; 7: 290-290. [Oral Communication]
Web of Science

 

Landl, E; Renner, W; Boehm, B; März, W No association of CX3CR1 gene variants with cardiovascular disease
Symposium2007; -Symposium Individualized Medicine in Complex Diseases; JUNE 21-23, 2007; Regensburg, GERMANY. [Oral Communication]

 

Landl, EM; Silbernagel, G; Fauler, G; Renner,W; Boehm, B; März, W Plasma levels of sitosterol and campesterol are not directly associated with the risk for coronary artery disease.
ÖGLMKC2007; -Gemeinsamer Kongress der Österreichischen Gesellschaft für Laboratoriumsmedizin und Klinische Chemie (ÖGLMKC) und der Deutschen Vereinten Gesellschaft für Klinische Chemie und Laboratoriumsmedizin (DGKL); SEP 05, 2007; Vienna, AUSTRIA. [Poster]

 

Prüller, F; Payer, S; Ramschak, H; Tiran, B; Böhm, B; März, W Endogenous thrombin potential in 3183 participants of the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Journal of Thrombosis and Haemostasis2007; 5(S2):O-T-91--XXIst Congress of the International Society on Thrombosis and Haemostasis (ISTH); JUL 6-12, 2007; Geneva, SWITZERLAND. [Oral Communication]

 

Prüller, F; Payer, S; Ramschak, H; Tiran, B; Böhm, B; März, W APC ratio in relationship to the factor V Leiden carrier status in 2754 participants of the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Hämostaseologie - Kongressausgabe 51. Jahrestgung der Gesellschaft für Thrombose und Hämostaseforschung e.V.2007; 27(1):A72--51. Jahrestgung der Gesellschaft für Thrombose und Hämostaseforschung e.V.; FEB 21-24, 2007; Dresden, GERMANY. [Poster]

 

Prüller, F; Ramschak, H; Maerz, W Endogenes Thrombin Potential im Klinischen Einsatz
Biomed Austria2007; 11--15. Jahrestagung der Biomedizinischen AnalytikerInnen; APR 27-28, 2007; Pörtschach, AUSTRIA. [Oral Communication]

 

Scharnagl, H; Stojakovic, T; Pittrow, D; Pieber, L; Freisinger, F; Boehler, S; Ruf, G; Maerz, W; Wittchen, HU Routine care treatment of patients at high risk for cardiovascular disease in Germany: Follow-up data from the detect study
ATHEROSCLER SUPPL. 2007; 8(1):131-131.-77th Annual Congress of the European Atherosclerosis Society; JUN 10-13; Helsinki, Finland. Doi: 10.1016/S1567-5688(07)71476-9 [Poster]
Web of Science FullText FullText_MUG

 

Scharnagl, H; Stojakovic, T; Seelhorst, U; Wellnitz, B; Boehm, BO; März, W High concentration of LDL triglycerides predicts all-cause and cardiovascular mortality in individuals with coronary artery disease (The Ludwigshafen Risk and Cardiovascular Health Study).
14. Jahrestagung der Österreichischen Atherosklerosegesellschaft – Austrian Atherosclerosis Society (AAS); MAI 11-12, 2007; St.Gilgen, Austria. 2007. [Oral Communication]

 

Scharnagl, H; Stojakovic, T; Seelhorst, U; Wellnitz, B; Boehm, BO; März, W High concentration of LDL triglycerides predicts all-cause and cardiovascular mortality in individuals with coronary artery disease.
37. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 29 - DEC 1, 2007; Maikammer, Deutschland. 2007. [Oral Communication]

 

Stojakovic, T; Assadian, A; Knöbl, P; Hübl, W; Senekowitsch, C; Hagmüller, GW; Eidher, U; Scharnagl, H; Winkelmann, BR; Boehm, BO; März, W Low HDL cholesterol and low HDL triglycerides in patients with symptomatic and asymptomatic high grade internal carotid artery stenosis.
Journal of Thrombosis and Haemostasis 2007; 5(S2):P-W-445.-XXIst Congress of the International Society on Thrombosis and Haemostasis (ISTH); JUL 6-12, 2007; Geneva, Switzerland. [Poster]

 

Stojakovic, T; Assadian, A; Knöbl, P; Hübl, W; Senekowitsch, C; Hagmüller, GW; Eidher, U; Scharnagl, H; Winkelmann, BR; Boehm, BO; März W Prevalence of elevated lipoprotein (a) among patients with symptomatic and asymptomatic high-grade carotid artery stenosis.
Hämostaseologie. 2007; 27(1):A88-A88.-51. Jahrestagung der Gesellschaft für Thrombose- & Hämastoseforschung e.V. (GTH); FEB 21-24, 2007; Dresden, Germany. [Poster]

 

Stojakovic, T; Assadian, A; Scharnagl, H; Hübl, W; Hagmüller, GW; Winkelmann, BR; Boehm, BO; Marz, W Patients with symptomatic and asymptomatic high grade internal carotid artery stenosis have lower concentrations of high density lipoproteins.
Clin Chem Lab Med, 2007; 45(8):A129-A130.-Congress of Clinical Chemistry and Laboratory Medicine; SEP 19-22, 2007; Vienna, Austria. [Poster]

 

Stojakovic, T; Scharnagl, H; Trauner, M; Wellnitz, B; Ursula Seelhorst, U; Winkelmann, BR; Boehm, BO; März W Serum gamma-glutamyltransferase, cardiovascular disease and mortality risk – the Ludwigshafen Risk and Cardiovascular Health Study.
37. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 29 - DEC 1, 2007; Maikammer, Deutschland. 2007. [Oral Communication]

 

Stojakovic, T; Scharnagl, H; Wellnitz, B; Seelhorst, U; Winkelmann, BR; Boehm, BO; Maerz, W Serum gamma-glutamyltransferase and cardiovascular mortality in subjects with coronary artery disease - The Ludwigshafen risk and cardiovascular health study
ATHEROSCLER SUPPL. 2007; 8(1):148-148.-77th Annual Congress of the European Atherosclerosis Society; JUN 10-13; Helsinki, Finland. Doi: 10.1016/S1567-5688(07)71544-1 [Poster]
Web of Science FullText FullText_MUG

 

Stojakovic, T; Scharnagl, H; Wellnitz, B; Seelhorst, U; Winkelmann, BR; Boehm, BO; März, W Serum gamma-glutamyltransferase and cardiovascular mortality in subjects with coronary artery disease – the Ludwigshafen Risk and Cardiovascular Health Study.
14. Jahrestagung der Österreichischen Atherosklerosegesellschaft – Austrian Atherosclerosis Society (AAS); MAI 11-12, 2007; St.Gilgen, Austria. 2007. [Poster]

 

Wascher, TC; Renner, W; Sourij, H; Schmölzer, I; Winkelmann, BR; Boehm, BO; Maerz, W; Der glukometabolische Phänotyp, nicht aber die Insulinresistenz sind prädiktiv für das Ausmaß der koronaren Herzkrankheit und die Mortalität bei koronarangiographierten Patienten. Eine Analyse der LURIC Population.
Abstracts zur 35. Jahrestagung der Österreichischen Diabetesgesellschaft2007; 119(S4):28-28.-Jahrestagung der Österreichischen Diabetesgesellschaft; NOV 29 - DEC 01, 2007; Innsbruck, AUSTRIA. [Poster]

 

Weihrauch, G; Dobnig, H; Scharnagl, H; Stojakovic, T; Marz, W Associations of Cystatin C with mortality data from the Ludwigshafen Risk and Cardiovascular Health Study (LURIC).
Clin Chem Lab Med, 2007; 45(8):A123-A123.-Congress of Clinical Chemistry and Laboratory Medicine; SEP 19-22, 2007; Vienna, Austria. [Poster]

 

Weihrauch, G; Dobnig, H; Scharnagl, H; Stojakovic, T; Seelhorst, U; Wellnitz, B; Winkelmann, BR; Boehm, BO; März, W Cystatin C independently associated with mortality in the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
37. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 29 - DEC 1, 2007; Maikammer, Deutschland. 2007. [Oral Communication]

 

Abedini, S; Jardine, A; Fellstrøm, B; Meinitzer, A; März, W; Bermann, G; Holdaas, H Asymmetric dimethylarginine (ADMA) predicts progression to graft failure and major cardiac events in renal transplant recipients (RTR).
J Am Soc Nephrol, 2006; 17(S):68A-68A.-Renal Week; Nov 14-19, 2006; San Diego, USA. [Oral Communication]

 

Fauler, G; Stojakovic, T; Putz-Bankuti, C; Gurakuqi, GC; Scharnagl, H; Marz, W; Trauner, M Atorvastatin in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid
ATHEROSCLER SUPPL. 2006; 7(3):583-583.-XIV. International Symposium on Atherosclerosis; JUNE 18-22, 2006; Rome, Italy. Doi: 10.1016/S1567-5688(06)82367-6 [Poster]
Web of Science FullText FullText_MUG

 

Fellström, G; Holdaas, H; Jardine, A; Maerz, W; on behalf of the ALERT study group Calcium, Phosphate, Parathyroid hormone and Osteoprotegerin as Risk Factors for Graft Loss in Renal Transplantation.
World Transplant Congress; JULY 22-27, 2006; Boston, USA. 2006. [Oral Communication]

 

Holdaas, H; Abedini, S; Jardine, A; Maes, B; März, W; Fellstrøm, B Parathyroid hormone and phosphate - risk factors for post-transplant cardiovascular disease?
J Am Soc Nephrol, 2006; 17(S):19A-19A.-Renal Week; Nov 14-19, 2006; San Diego, USA. [Oral Communication]

 

Holdaas, H; Abedini, S; Tiran, B; Weihrauch, G; März, W; Maes, B; Fellstrom, B; Bermann, G; Jardine, A Parathyroidea hormone (PTH) and phosphorus - modifiable risk factor for cardiac endpoints and all-cause mortality in renal transplant recipients?
World Transplant Congress; JULY 22-29, 2006; Boston, USA. 2006. [Oral Communication]

 

Jardine, A; März, W; Fellstrøm, B; Weihrauch, G; Holdaas, H Osteoprotegerin – a novel risk factor post-transplant cardiovascular disease.
J Am Soc Nephrol, 2006; 17(S):231A-231A.-Renal Week; NOV 14-19, 2006; San Diego, USA. [Poster]

 

Lublinghoff, N; Winkler, K; Winkelmann, B; Boehm, B; Marz, W; Hoffmann, M Genetic variants of the promoter of the heme oxygenase-1 gene and their influence on cardiovascular disease.
ATHEROSCLER SUPPL. 7(3):143-143.-XIV. International Symposium on Atherosclerosis; JUNE, 18-22; Rome, ITALY. Doi: 10.1016/S1567-5688(06)80572-6 [Poster]
Web of Science FullText FullText_MUG

 

Mangge, H; Lang, N; Sargsyan, K; Pilz, S; Almer, G; Borkenstein, M; Horejsi, R; Möller, R; März, W STyrian Juvenile OBesity (STYJOBS)-Neue Daten und erste Ergebnisse aus der Interventionsgruppe.
52. Ausseer Symposion der Wissenschaftlichen Gesellschaft der Ärzte in der Steiermark; MAY 11-13, 2006; Aussee, Austria. 2006. [Poster]

 

Mangge, H; Pilz, S; Sargsyan, K; Lang, N; Horejsi, R; Möller R, Dimitrova, R; Weihrauch, G; März, W Resistin correlates with low grade inflammation, but not with preatherosclerosis and insulin resistance in obese juveniles.The STYrian Juvenile OBesity Study (STYJOBS).
Atherosclerosis Supplements . 7(3):310-310.-XIV International Symposium on Atherosclerosis; June 18-22, 2006; Rome, Italy. Doi: 10.1016/S1567-5688(06)81243-2 [Oral Communication]
Web of Science FullText FullText_MUG

 

Mangge, H; Sargsyan, K; Lang, N; Pilz, S; Horejsi, R; Moller, R; Almer, G; Windhaber, J; Schober, P; Scharnagl, H; Stojakovic, T; Marz, W The STYrian Juvenile OBesity Study (STYJOBS)
INT J OBESITY. 2006; 30: S6-S6.-16th Workshop of the European Childhood Obesity Group (ECOG) ; JUN 1-3, 2006; Rzeszów, POLAND. [Oral Communication]
Web of Science

 

März, W; Weihrauch, G; Tiran, B; Fellstrøm, B; Jardine, A; Holdaas, H Interleukin 6 and C-reactive protein as predictors of renal end points in renal transplant recipients: the Assessment of Lescol in Renal Transplant (ALERT) trial.
World Transplant Congress; JULY, 22-27; Boston, USA. 2006. [Poster]

 

Mayer, CM; Gruber, HJ; Landl, EM; Pailer, S; Scharnagl, H; Maerz, W Rosuvastatin reduces interleukin-6 induced C-reactive protein expression via STAT3 and C/EBP inhibition
ATHEROSCLER SUPPL. 7(3):570-570.-XIV. International Symposium on Atherosclerosis; JUNE, 18-22; Rome, Italy. Doi: 10.1016/S1567-5688(06)82307-X [Poster]
Web of Science FullText FullText_MUG

 

Pilz, S; Mangge, H; Tiran, B; Boehm, B; Winkelmann, B; März, W High adiponectin is independently associated with total mortality and cardiovascular mortality in coronary artery disease.
Atherosclerosis Supplements. 7(3):72--XIV International Symposium on Atherosclerosis; June 18-22, 2006; Rome, Italy. [Poster]
Web of Science

 

Pilz, S; Scharnagl, H; Tiran, B; Boehm, BO; Marz, W Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease
ATHEROSCLER SUPPL. 7(3):72-72.-XIV. International Symposium on Atherosclerosis; JUNE, 18-22; Rome, Italy. [Poster]
Web of Science

 

Prüller, F; Bach, J; Seelhorst, U; Wellnitz, B; Winkelmann, BR; Böhm, BO; März, W; Hellstern, P D-dimers and soluble fibrin independently predict total mortality in individuals with or without stable coronary artery disease (The Ludwigshafen Risk and Cardiovascular Health Study).
Proceedings and Abstracts from the 19th International Congress on Thrombosis2006; 35(1-2):A38--19th International Congress on Thrombosis; MAY 14-18, 2006; Tel-Aviv, ISRAEL. (ISBN: 3-8055-8111-4 ) [Poster]

 

Scharnagl, H; Meinitzer, A; Pilz, S; Stojakovic, T; Seelhorst, U; Wellnitz, B; Böhm, BO; März, W Total and cardiovascular mortality in The Ludwigshafen Risk and Cardiovascular Health Study (LURIC): Associations with adiponectin, asymetrical dimethylarginine, free fatty acids, and LDL triglycerides.
13. Jahrestagung der Austrian Atherosclerosis Society (AAS); MAI 5-6, 2006; St. Gilgen, AUSTRIA. 2006. [Oral Communication]

 

Scharnagl, H; Vogel, M; Abletshauser, C; Freisinger, F; Stojakovic, T; Maerz, W Efficacy and safety of morning administration of fluvastatin extended release formulation is equivalent to evening administration.
MED KLIN. ; 101: A109-A109.-112. Kongress der Deutschen Gesellschaft für Innere Medizin; APR 22-26, 2006; Wiesbaden, Germany. [Poster]
Web of Science

 

Scharnagl, H; Vogel, M; Abletshauser, C; Freisinger, F; Stojakovic, T; Maerz, W Efficacy and safety of morning administration of fluvastatin extended release formulation is equivalent to evening administration
ATHEROSCLER SUPPL. 7(3):576-576.-XIV. International Symposium on Atherosclerosis; JUNE, 18-22; Rome, Italy. Doi: 10.1016/S1567-5688(06)82332-9 [Poster]
Web of Science FullText FullText_MUG

 

Scharnagl, H; Vogel, M; Abletshauser, C; Freisinger, F; Stojakovic, T; März, W Efficacy and safety of morning administration of fluvastatin extended release formulation is equivalent to evening administration.
Arteriosklerose: Neue Konzepte, Risikofaktoren und Targets; Heinle H, Schulte H, von Eckardstein A (Hrsg.) 2006; 20: 207-211.-20. Jahrestagung der Deutschen Gesellschaft für Arterioskleroseforschung; März 16-18; Blaubeuren, Deutschland. (ISBN: 978-3-936423-05-1 ) [Poster]

 

Skerget, M; Wimmer, G; Thaller, E; März, W; Meinitzer, A; Spary, A; Brodmann, M; Bratschko, RO; Pilger, E; Seinost, G Führt eine verminderte Ratio von L-Arginin und asymetrischem Dimethylarginin bei parodontalen Erkrankungen zu einer endothelialen Dysfunktion?
-DGIM; 22.04.-26.04.06; Wiesbaden, Deutschland. [Poster]

 

Skerget, M; Wimmer, G; Thaller, E; Marz, W; Spary, A; Brodmann, M; Bratschko, R; Pilger, E; Seinost, G Does a reduced ratio of L-arginine and asymmetric dimethyl arginine in parodontal diseases lead to an endothelial dysfunction?
MED KLIN. 101: A9-A10.-112. Jahrestagung der deutschen Gesellschaft für Innere Medizin; April 22-26, 2006; Wiesbaden, Deutschland. [Poster]
Web of Science

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Gurakuqi, G; Scharnagl, H; Stadlbauer, V; Stauber, R; Maerz, W; Trauner, M Atorvastatin in patients with primary biliary cirrhosis and incomplete response to ursodeoxycholic acid.
Clin Chem Lab Med. 44(9):A207-A207.-First Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC); OCT 4-7, 2006; Salzburg, Austria. [Poster]

 

Stojakovic, T; Scharnagl, H; Freisinger, F; Pittrow, D; Glaesmer, H; Boehler, S; Ruf, G; Maerz, W; Wittchen, HU Prevalence of obesity and its importance to cardiovascular diseases in germany: Findings from the DETECT study
ATHEROSCLER SUPPL. 7(3):53-53.-XIV. International Symposium on Atherosclerosis; JUNE, 18-22; Rome, Italy. Doi: 10.1016/S1567-5688(06)80170-4 [Poster]
Web of Science FullText FullText_MUG

 

Stojakovic, T; Scharnagl, H; März, W; Winkelmann, BR; Boehm, BO; Schmut O Atherogenic lipoproteins are risk factors for retinal artery occlusion or retinal vein occlusion.
36. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 30 - DEC 2, 2006; Maikammer, Deutschland. 2006. [Oral Communication]

 

Stojakovic, T; Scharnagl, H; Weger, A; Haas, A; März, W; Steinbrugger, I; Winkelmann, BR; Boehm, BO; Schmut, O Atherogenic Lipoproteins as Risk Factors for Retinal Artery Occlusion or Retinal Vein Occlusion
13. Jahrestagung der Austrian Atherosclerosis Society (AAS); MAI 5-6, 2006; St. Gilgen, AUSTRIA. 2006. [Poster]

 

Stojakovic, T; Scharnagl, H; Winkelmann, BR; Boehm, BO; März, W Elevated LDL triglycerides, but not LDL cholesterol in male patients with venous thromboembolism.
Hämostaseologie 2006; 26(1):A30-A30.-50. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung e. V. (GTH); FEB 15-18, 2006; Basel, Switzerland. [Poster]

 

Weihrauch, G; Tiran, B; März, W; Jardine, A; Holdaas, H; Fellstrom, B Interleukin 6, C-reactive protein and cardiovascular risk in renal transplant recipients: the Assessment of Lescol in Renal Transplant (ALERT) trial
World Transplant Congress; JULY 22-27, 2006; Boston, USA. 2006. [Oral Communication]

 

Winkler, K; Winkelmann, BR; Marz, W Lipoprotein-associated phospholipase A2 activity predicts cardiac and total mortality independently of angiographic coronary artery disease status, LDL-size, C-reactive protein, and other risk factors
EUR HEART J. 27: 671-671.-European Society of Cardiology 2006 World Congress; SEP, 2-6; Barcelona, Spain. [Poster]
Web of Science

 

Winklhofer-Roob, BM; Sargsyan, K; Maritschnegg, M; Pilz, S; Dimitrova, R; Weihrauch, G; Almer, G; Scharnagl, H; Stojakovic, T; Borkenstein, M; Marz, W; Mangge, H Relations between antioxidants and biomarkers of consumption of fruits and vegetables and body mass index (BMI) in juvenile obesity
FREE RADICAL RES. 40: S141-S141.-13th Biennial Meeting of the Society-for-Free-Radical-Research-International; AUG 15-19; Davos, Switzerland. [Poster]
Web of Science

 

Winklhofer-Roob, M; Sargsyan, K; Maritschnegg, M; Pilz, S; Dimitrova, R; Weihrauch, G; Almer, G; Scharnagl, H; Stojakovic, T; Borkenstein, M; März, W; Mangge, H Relations between antioxidants and biomarkers of consumption of fruits and vegetables and body mass index in The STYrian Juvenile OBesity Study (STYJOBS).
Austrian Atherosclerosis Society (AAS) ; Mai 5-6, 2006; St.Gilgen Wolfgangsee, Austria. 2006. [Oral Communication]

 

Wunderlich, T; Hoffmann, M; Friedrich, I; Wieland, H; Hanefeld, M; Marz, W; Winkler, K Atorvastatin and LDL profile in NIDDM (alpin study)
ATHEROSCLER SUPPL. 7(3):581-581.-XIV. International Symposium on Atherosclerosis; JUNE, 18-22; Rome, Italy. Doi: 10.1016/S1567-5688(06)82355-X [Poster]
Web of Science FullText FullText_MUG

 

Ahl, D; Hoffmann, MM; Seelhorst, U; Winkelmann, BR; Boehm, BO; Maerz, WG The C-514T polymorphism in the promoter of the gene for hepatic lipase. association with coronary heart disease, myocardial infarction and all cause mortality in the Ludwigshafen risk and cardiovascular health study
CIRCULATION 2005 112: -.
Web of Science

 

Bohler, S; Scharnagel, H; Freisinger, F; Stojakovic, T; Glaesmer, H; Klotsche, J; Kirch, W; Schneider, H; Stalla, G; Lehnert, H; Silber, S; Wittchen, HU; Marz, W The NCEP guidelines in a primary care sample in Germany: Degree of unmet needs: Results from the DETECT study.
EUR J CLIN PHARMACOL 2005 61: 703-703.
Web of Science

 

Grammer, TB; Renner, W; Hoffmann, MM; Winkelmann, BR; Boehm, BO; Marz, W SOD3 R231G polymorphism associated with coronary artery disease and myocardial infarction in the Ludwigshafen risk and cardiovascular health study.
Atheroscl Suppl2005; 6(1):4-4.-75th Congress of the European Atherosclerosis Society; APR 23-26, 2005; Prague, CZECH REPUBLIC. [Poster]

 

Grammer, TB; Renner, W; Winkelmann, BR; Boehm, BO; Marz, W DELTAF508 heterozygosity in cystic fibrosis associated with coronary artery disease in the ludwigshafen risk and cardiovascular health study.
Atheroscl Suppl2005; 6(1):13-13.-75th Congress of the European Atherosclerosis Society; APR 23-26, 2005; Prague, CZECH REPUBLIC. [Poster]

 

Gruber, HJ; Mayer, CM; Landl, EM; Panzenbock, U; Sattler, W; Scharnagl, H; Marz, W Atorvastatin induces glucose uptake via GLUT-4 in L6 skeletal muscle cells
ATHEROSCLER SUPPL. 2005; 6: 108-108.-75th Congress of the European-Atherosclerosis-Society; APR 23-26, 2005; Prague, CZECH REPUBLIC. Doi: 10.1016/S1567-5688(05)80428-3 [Poster]
Web of Science FullText FullText_MUG

 

Mangge, H; Sargsyan, K; Pilz, S; Horejsi, R; Moller, R; Dimitrova, R; Weihrauch, G; Almer, G; Scharnagl, H; Stojakovic, T; Borkenstein, M; Marz, W The STYrian Juvenile Obesity Study (STYJOBS)
INT J OBESITY 2005 29: -.
Web of Science

 

Mayer, C; Gruber, HJ; Landl, E; Scharnagl, H; März, W STATIN INDUCED INHIBITION OF CRP EXPRESSION IN PRIMARY HUMAN HEPATOCYTES.
Atherosclerosis Supplement2005; 6: 109-109.-Congress of the European Atherosclerosis Society; April 23-26, 2005; Prague, Czech Republic. [Poster]

 

Mayer, C; Gruber, HJ; Landl, EM; Pailer, S; Scharnagl, H; März, W Rosuvastatin reduces Il-6 induced CRP expression via STAT3 and C/EBP inhibition.
35.Jahretagung des Arbeitskreises Klinischer Lipidstoffwechsel, Maikammer; NOV 25-27, 2005; Maikammer, GERMANY. 2005. [Oral Communication]

 

Pilz, S; Mangge, H; Boehm, BO; Winkelmann, BR; März, W High adiponectin is independently associated with total mortality and cardiovascular mortality in coronary artery diease (The Ludwigshafen Risk and Cardiovascular Health Study)
Abstracts der 35. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel". 2005; -35. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27; Maikammer, GERMANY. [Oral Communication]

 

Pilz, S; Sargsyan, K; Horejsi, R; Moller, R; Dimitrova, R; Weihrauch, G; Almer, G; Scharnagl, H; Stojakovic, T; Borkenstein, M; Marz, W; Mangge, H Resistin correlates with low-grade inflammation, but not with preatherosclerosis and insulin resistance in obese juveniles - The STYrian Juvenile OBesity Study (STYJOBS)
INT J OBESITY 2005 29: -.
Web of Science

 

Renner, W; Nauck, M; Winkelmann, BR; Hoffmann, MH; Scharnagl, H; Mayer, V; Boehm, BO; Marz, W Angiotensinogen haplotypes and angiotensinogen levels
ATHEROSCLER SUPPL 2005 6: 59-59. Doi: 10.1016/S1567-5688(05)80235-1 [Poster]
Web of Science FullText FullText_MUG

 

Sargsyan, K; Meinitzer, A; Pilz, S; Horejsi, R; Moller, R; Dimitrova, R; Weihrauch, G; Almer, G; Scharnagl, H; Stojakovic, S; Borkenstein, M; Marz, W; Mangge, H Serum levels of asymmetric dimethylarginine exhibit a sharp decline during adolescence, which is attenuated in obesity - The STYrian Juvenile Obesity Study (STVJOBS)
INT J OBESITY 2005 29: -.
Web of Science

 

Scharnagl, H; Stojakovic, T; Winkler, K; Marz, W; Boehm, B HMG-COA reductase inhibitor cerivastatin lowers advanced glycosylation end-products in patients with type 2 diabetes
ATHEROSCLER SUPPL 2005 6: 78-78. Doi: 10.1016/S1567-5688(05)80311-3
Web of Science FullText FullText_MUG

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Stadlbauer, V; Gurakuqi, G; Stauber, RE; März, W; Trauner, M Atorvastatin in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.
35. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27, 2005; Maikammer, Deutschland. 2005. [Oral Communication]

 

Stojakovic, T; Scharnagl, H; Freisinger, F; Tiran, A; Pittrow, D; Glaesmer, H; Boehler, S; Ruf, G; Marz, W; Wittchen, HU Routine care treatment of type 2 diabetes in Germany (detect study)
ATHEROSCLER SUPPL 2005 6: 151-151. Doi: 10.1016/S1567-5688(05)80588-4
Web of Science FullText FullText_MUG

 

Stojakovic, T; Scharnagl, H; Weger, M; Schmut, O; Haas, A; März, W Lipoprotein Pattern in Patients with Retinal Artery Occlusion or Retinal Vein Occlusion
Journal of Thrombosis and Haemostasis2005; 3(S1):P2380--XXth Congress of the International Society on Thrombosis and Haemostasis (ISTH); AUG 6-12, 2005; Sydney, Australia. [Poster]

 

Winklhofer-Roob, BM; Sargsyan, K; Maritschnegg, M; Pilz, S; Dimitrova, R; Weihrauch, G; Almer, G; Scharnagl, H; Stojakovic, T; Borkenstein, M; Marz, W; Mangge, H Relations between antioxidants and biomarkers of consumption of fruits and vegetables and body mass index in The STYrian Juvenile OBesity Study (STYJOBS)
INT J OBESITY 2005 29: -.
Web of Science

 

Fauler, G; März, W; Abletshauser, C; Erwa, W; Loser, R Fluvastatin ER formulation reduces cholesterol biosynthesis independent of daytime of administration
ATHEROSCLER SUPPL 2004 5: 117-118.
Web of Science

 

Gruber, H-J; Landl, E; Mayer, CM; Panzenböck, U; Sattler, W; Scharnagl, H; März, W Improved glucose uptake in L6 cells by HMG-CoA reductase inhibition
Jahrestagung2004; -34. Jahrestagung des Arbeitskreises Klinischer Lipidstoffwechsel; NOV 25, 2004; Maikammer, GERMANY. [Oral Communication]

 

Gruber, HJ; Mayer, C; Landl, E;Panzenböck, U; Sattler, W; Scharnagl, H; März, W IMPAIRED GLUCOSE UPTAKE IN L6 CELLS BY HMG-CO-A-REDUCTASE INHIBITION.
XV Symposium on Drugs Affecting Lipid Metabolism.; October 24-27, 2004; Venice, Italy. 2004. [Poster]

 

Hubmann, H; Pilz, S; Borkenstein, M; März, W; Stroedter, L; Griesl, A; Mangge, H Low grade inflammation in juvenile obesity and type I diabetes associated with preatherosclerosis
ATHEROSCLER SUPPL 2004 5: 31-31.
Web of Science

 

Khuseyinova, N; Imhof, A; Rothenbacher, D; Trischler, G; Scharnagl, H; Maerz, W; Brenner, H; Koenig, W Association between lipoprotein-associated phospholipase A2 and coronary artery disease: focus on its relationship with lipoproteins and markers of inflammation and hemostasis
EUR HEART J 2004 25: 443-443.
Web of Science

 

Khuseyinova, N; Imhof, A; Rothenbacher, D; Trischler, G; Scharnagl, H; Maerz, W; Brenner, H; Koenig, W Association between lipoprotein-associated phospholipase A2 and coronary artery disease: Focus on its relationship with lipoproteins and markers of inflammation and hemostasis
CIRCULATION 2004 110: 775-775.
Web of Science

 

Koenig, W; Hoffmann, M; Illig, T; Loewel, H; Boehm, B; Holmer, S; Rothenbacher, D; Maerz, W Genetic variation in Fc-gamma; Receptor II a and risk of coronary heart disease: negative results from two large independent populations
EUR HEART J 2004 25: 532-532.
Web of Science

 

Maerz, W; Scharnagl, H; Winkler, K; Tiran, A; Nauck, M; Boehm, BO; Winkelmann, BR Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary disease(The Ludwigshafen risk and cardiovascular health study)
CIRCULATION 2004 110: 118-118.
Web of Science

 

Marz, W; Hoffmann, M; Renner, W; Boehm, B; Winkelman, B Alanine to serine polymorphism at position 986 of the calcium sensing receptor associated with coronary heart disease and myocardial infarction. (The Ludwigshafen Risk and Cardiovascular Health Atudy)
ATHEROSCLER SUPPL 2004 5: 87-87.
Web of Science

 

Marz, W; Nauck, M; Hoffmann, M; Nagel, D; Bohm, B; Koenig, W; Winkelmann, B G(-30)A polymorphism in the promoter of the glucokinase gene associated with angiographic coronary artery disease and glucose metabolism
ATHEROSCLER SUPPL 2004 5: 87-87.
Web of Science

 

Marz, W; Scharnagl, H; Nauck, M; Bohm, B; Winkelman, B The apolipoprotein E polymorphism is associated with circulating C-reactive protein (The Ludwigshafen Risk and Cardiovascular Health Study)
ATHEROSCLER SUPPL 2004 5: 87-87.
Web of Science

 

Marz, W; Scharnagl, H; Nauck, M; Tiran, A; Bohm, B; Winkelmann, B Low density lipoprotein triglycerides assuciated with low grade systemic inflammation, adhesion molecules and stable angiographic coronary disease
ATHEROSCLER SUPPL 2004 5: 12-12.
Web of Science

 

Mayer, C; Gruber, HJ; Landl, E; Scharnagl, H; März, W EFFECT OF HMG-CoA REDUCTASE INHIBITION ON CRP EXPRESSION IN PRIMARY HUMAN HEPATOCYTES.
XV Symposium on Drugs Affecting Lipid Metabolism.; October 24-27, 2004; Venice, ITALY. 2004. [Poster]

 

Renner, W; Hoffmann, M; Winkelmann, B; Scharnagl, H; Bohm, B; Marz, W The P12A polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene associated premature coronary heart disease and myocardial infraction. (The Ludwigshafen Risk and Cardiovascular Health Study)
ATHEROSCLER SUPPL 2004 5: 89-89.
Web of Science

 

Scharnagl, H; Freisinger, F; Tiran, A; Stojakovic, T; Pittrow, D; Glaesmer, H; Boehler, S; Ruf, G; März, W; Wittchen, H The gap between treatment guidelines and routine care treatment patters in the management of high risk patients: Findings from the detect study
ATHEROSCLER SUPPL. ATHEROSCLER SUPPL2004; 5: 150-150.-74th Congress of the European-Atherosclerosis-Society; APR 17, 2004; Seville, SPAIN.
Web of Science

 

Stojakovic, T; Scharnagl, H; Freisinger, F; Tiran, A; Pittrow, D; Glaesmer, H; Boehler, S; Ruf, G; März, W; Wittchen, HU The gap between treatment guidelines and routine care treatment patterns in the management of high risk patients: findings from the DETECT study.
34. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27, 2004; Maikammer, Deutschland. 2004. [Oral Communication]

 

Winkler, K; Abletshauser, C; Friedrich, I; Hoffmann, M; Wieland, H; Marz, W Fluvastatin slow-release lowers PAF-AH activity: A placebo controlled trial in patients with type 2 diabetes
ATHEROSCLER SUPPL 2004 5: 22-22.
Web of Science

 

Winkler, K; Abletshauser, C; Friedrich, I; Hoffmann, MM; Wieland, H; Marz, W Fluvastatin slow-release lowers PAF-AH activity: a placebo controlled trial in patients with type 2 diabetes
EUR HEART J 2004 25: 507-507.
Web of Science

 

Gruber, HJ; Landl, E; Winter, E; Friedl, N; Tiran, A; März, W; Tiran, B Cell Type Specific NO Synthases Response During an Infection with Chlamydophila pneumoniae in Cell Culture
5th International Congress on Coronary Artery Disease; October 19-22, 2003; Florence, ITALY. 2003. [Poster]

 

Hoffmann, MM; Winkelmann, BR; Muller, A; März, W The G494A (H131R) variant of the CRP-receptor FCGRIIA is not associated with coronary artery disease and myocardial infarction
ATHEROSCLER SUPPL 2003 4: 21-21.
Web of Science

 

Krane, V; März, W; Ruf, G; Ritz, E; Wanner, C Atorvastatin in type 2 diabetic patients on Hemodialysis (4D-Study): Baseline characteristics and 1(st) interim analysis.
J AMER SOC NEPHROL 2003 14: 496A-496A.
Web of Science

 

Marz, W; Krane, V; Olschewski, M; Ruf, G; Ritz, E; Wanner, C Atorvastatin in patients with type 2 diabetes on haemodialysis: design and patient characteristics of a double-blind clinical trial (die deutsche diabetes dialyse study)
EUR HEART J 2003 24: 461-461. Doi: 10.1016/S0195-668X(03)95360-7
Web of Science FullText FullText_MUG

 

Nauck, M; März, W; Hoffmann, MM; Nagel, D; Boehm, BO; Winkelmann, BR The G(-30)A polymorphism in the promoter of the glucokinase gene is associated with angiographic coronary artery disease, type 2 diabetes mellitus and glucose metabolism
ATHEROSCLER SUPPL 2003 4: 22-22. Doi: 10.1016/S1567-5688(03)90090-0
Web of Science FullText FullText_MUG

 

Nauck, MS; März, W; Nagel, D; Boehm, BO; Winkelmann, BR Cystatin C is independently associated with angiographic coronary artery disease in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
CLIN CHEM 2003 49: A55-A55.
Web of Science

 

Scharnagl, H; Kist, M; Grawitz, AB; Koenig, W; Wieland, H; März, W Helicobacter pylori eradication increases high density lipoproteins
ATHEROSCLER SUPPL 2003 4: 73-73. Doi: 10.1016/S1567-5688(03)90317-5
Web of Science FullText FullText_MUG

 

Scharnagl, H; Winkler, K; Nauck, MA; Boehm, BO; Winkelmann, BR; März, W Low density lipoprotein triglycerides are associated with low grade systemic inflammation, adhesion molecules and angiographic coronary artery disease.
33. Jahrestagung des Arbeistkreieses Lipidstoffwechsel; NOV, 27-29, 2003; Maikammer, Germany. 2003. [Oral Communication]

 

Wanner, C; Krane, V; Olschewski, M; Ruf, G; März, W; Ritz, E The 4D Trial: Is lipid lowering therapy effective in diabetic patients on hemodialysis?
CIRCULATION 2003 108: 749-749.
Web of Science

 

Winkler, K; Ruf, G; Krane, V; Wieland, H; Ritz, E; Wanner, C; März, W LDL subtraction profile at baseline in a double-blind clinical trial with atorvastatin in patients with type 2 diabetes on hemodialysis (Die Deutsche Diabetes Dialysis Study)
ATHEROSCLER SUPPL 2003 4: 131-132. Doi: 10.1016/S1567-5688(03)90565-4
Web of Science FullText FullText_MUG

 

Spaniol, M; Kaufmann, P; Beier, K; Wuethrich, J; Scharnagl, H; Maerz, W; Kraehenbuehl, S Mechanism of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate
J HEPATOL 2002 36: 23-23. Doi: 10.1016/S0168-8278(02)80065-4
Web of Science FullText FullText_MUG

 

Imhof, A; Rothenbacher, D; Hoffmeister, A; Brenner, H; Maerz, W; Nauck, M; Scharnagl, H; Koenig, W Plasma lipoprotein(a) levels are independently associated with chronic coronary artery disease: results of a large case-control study
EUR HEART J 2000 21: 628-628.
Web of Science

 

Scharnagl, H; Tisljar, U; Gierens, H; Wieland, H; Marz, W Effect of pravastatin on endothelial NO-synthesis in comparison to other HMG-CoA-reductase inhibitors
ATHEROSCLEROSIS 1999 144: 29-29. Doi: 10.1016/S0021-9150(99)80109-9
Web of Science FullText FullText_MUG

 

Schlemmer, E; Hoffmann, MM; Scharnagl, H; Neuhaus, G; Wieland, H; Marz, W Expression and functional characterization of the extracellular domain II of the LDL receptor related protein
ATHEROSCLEROSIS 1999 144: 111-111. Doi: 10.1016/S0021-9150(99)80430-4
Web of Science FullText FullText_MUG

 

Gierens, H; Nauck, MS; Roth, M; Schinker, R; Scharnagl, H; Wieland, H; Maerz, W Interleukin 6 stimulates the expression of LDL receptors via the cis-acting sterol-responsive element (SRE)
CIRCULATION 1998 98: 107-107.
Web of Science

 

Marz, W; Scharnagl, H; Abletshauser, C; Wieland, H; Baumstark, M Effect of fluvastatin on small dense low density lipoproteins in postmenopausal women with an atherogenic lipoprotein phenotype
ATHEROSCLEROSIS 1997 134: 129-129. Doi: 10.1016/S0021-9150(97)88699-6
Web of Science FullText FullText_MUG

 

Marz, W; Scharnagl, H; Winkler, K; Gierens, H; Nauck, M; Hoffmann, M; Klima, B; Schliack, M; Loser, R; Lang, G; Gross, W; Wieland, H Lifibrol (K12.148): First member of a new class of hypolipidemic drugs?
ATHEROSCLEROSIS 1997 130: 18-18.
Web of Science

 

Nauck, M; Scharnagl, H; Koster, W; Nissen, H; Marz, W; Wieland, H Mutations in the genes encoding the low-density lipoprotein receptor and apolipoprotein B in Southwest Germany
ATHEROSCLEROSIS 1997 134: 70-71. Doi: 10.1016/S0021-9150(97)88436-5
Web of Science FullText FullText_MUG

 

Scharnagl, H; Feussner, G; Acar, J; Wieland, H; Marz, W Apolipoprotein E deficient remnant lipoproteins and recombinant apolipoprotein E: A new model to characterize the interaction of apolipoprotein E with lipoprotein receptors and proteoglycans
ATHEROSCLEROSIS 1997 134: 361-361. Doi: 10.1016/S0021-9150(97)89839-5
Web of Science FullText FullText_MUG

 

Winkler, K; Schafer, J; Klima, B; Scharnagl, H; Nuber, C; Grathwohl, D; Koster, W; Wieland, H; Marz, W Influence of lifibrol therapy on apoB metabolism in mired hyperlipidemia and hypercholesterolemic patients
ATHEROSCLEROSIS 1997 134: 135-135. Doi: 10.1016/S0021-9150(97)88728-X
Web of Science FullText FullText_MUG

 

Winkler, K; Scharnagl, H; Hoschutzky, B; Hoffmann, MM; Friedrich, I; Wieland, H; Marz, W Apolipoprotein E and beta-A4 amyloid are immunologically and functionally related
ATHEROSCLEROSIS 1997 134: 21-21. Doi: 10.1016/S0021-9150(97)88201-9
Web of Science FullText FullText_MUG

 

Schaefer, JR; Scharnagel, H; Baumstark, M; Schweer, H; Winkler, K; Maisch, B; Steinmetz, A; Maerz, W Increased in vivo HDL-ApoA-I production in homozygous familial defective apolipoprotein B-100.
CIRCULATION 1996 94: 3414-3414.
Web of Science

 

MONDORF, UF; SIEKMEIER, R; MARZ, U; SCHARNAGL, H; GROSS, W; SCHOEPPE, W CHOLESTEROL LOADING OF RAT MESANGIAL CELLS LEADS TO INCREASED DEGRADATION OF LIPOPROTEIN(A)
KIDNEY INT. 47: 989-989.
Web of Science

 

© Med Uni GrazImprint